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Summary 
 
The food vacuole, the site of haemoglobin degradation in malaria parasites is 
unique to the Plasmodium genus and therefore represents an invaluable target 
for the development of antimalarial compounds. This organelle and the essential 
process which occur within it, have been well characterised in P. falciparum, 
however knowledge is lacking as to the nature of this cellular compartment in 
other human malaria species. Due to the restricted host cell preference of P. 
vivax, in vitro culture of the parasite remains a challenge. The in vitro culture-
adapted strains of the closely related primate malaria P. knowlesi and its 
recently developed transfection system, identify this parasite as a versatile tool 
to study “vivax-like” parasite biology. In the studies described in this thesis, the 
food vacuole biology of P. knowlesi (which also causes zoonotic disease in 
humans) is investigated to highlight differences in this organelle which may exist 
between parasite species.  
To compare the food vacuole morphology of the phylogenetically related 
parasites P. vivax, P. knowlesi and P. cynomolgi with P. falciparum, a 
combination of staining techniques and expression of fluorescent fusion food 
vacuole-resident proteins with live confocal microscopy is used. Multiple food 
vacuoles which are actively degrading haemoglobin were observed in the “vivax-
type” parasites, in contrast to a single, large food vacuole in P. falciparum. 
Electron microscopy is also used to complement these studies. 
PlasmepsinIV (PM4) is one of the key enzymes involved in haemoglobin 
degradation. The pkpm4 locus in P. knowlesi was modified to generate a copy of 
pkpm4 tagged with the FKBP (FK506 binding protein)-destabilisation domain 
(DD), creating parasites (pkpm4DD) which express an unstable PkPM4 protein 
which is only stabilised in the presence of the compound Shield-1. In amino 
acid-limited medium, parasites depend on haemoglobin degradation for a source 
of amino acids. In the absence of Shield-1, the parasites remain viable but there 
is a detrimental effect on both appearance and growth rate of pkpm4DD 
parasites in amino acid-limited medium, while the wild-type P. knowlesi remains 
unaffected, highlighting the role of PkPM4 in haemoglobin degradation, but 
suggesting that the enzyme is not essential for asexual viability. 
The food vacuole is also the proposed target for chloroquine, a drug which was 
successfully used to treat human malaria for many years, but is now 
dramatically less efficient for the treatment of P. falciparum due to the 
emergence of resistance. Mutations in PfCRT, a channel-like protein on the food 
vacuole membrane are implicated in chloroquine resistance in P. falciparum 
although no mutations in the PvCRT homologue have been identified in resistant 
P. vivax, indicating a difference in resistance mechanism of both parasites. To 
evaluate if PfCRT is capable of modulating drug susceptibility in a “vivax-type” 
parasite, a chloroquine resistant PfCRT allele was overexpressed in P. knowlesi, 
resulting in a four-fold increase in tolerance to chloroquine, indicating that PfCRT 
is capable of modulating chloroquine sensitivity in a “non-falciparum” parasite. 
These studies demonstrate the value of a versatile in vitro culture and 
transfection system in a parasite phyogenetically closely related to the second 
most important human malaria parasite, and utilise it to highlight some key 
differences which exist between malaria species in an important drug target. 
Research on P. knowlesi into fundamental biological processes can provide 
important insight into “vivax-like” parasite biology, as well as provide an 
indispensable tool for drug and vaccine studies. 
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Zusammenfassung 
Die Nahrungsvakuole ist der Ort an dem der Abbau des Hämoglobins im Malaria 
Parasiten stattfindet; diese Vakuole ist einzigartig für den Genus Plasnodium und 
repräsentiert somit ein unschätzbares Ziel zur Entwicklung für Anti-Malaria 
Komponenten. Diese Organelle und der wichtige Prozess, der in ihr ablauft, ist 
sehr gut karakterisiert für P. falciparum, für andere  Malaria Arten des Menschen 
jedoch fehlt das Wissen über die Art dieser zellulären Komponente. Auf Grund 
der Vorliebe von P vivax für eine bestimmte Wirtszelle, bleibt die in vitro Kultur 
des Parasiten eine Herausforderung. Ein Ausweg bietet der nah verwandte 
Malaria Parasit, P. knowlesi: Die an eine in vitro Kultur angepassten Stämme 
und ein vor kurzem entwickeltes Transfektionssystems kennzeichnen diesen 
Parasiten als vielseitiges Werkzeug, um eine ‘vivax-ähnliche’ Biologie zu 
studieren. Die Biologie der Nahrungsvakuole von P. knowlesi, der auch Zoonose-
Krankheiten beim Menschen verursachen kann, wird in den Studien zu dieser 
Diplomarbeit beschrieben; die Zielsetzung der Arbeit war es, die Unterschiede 
hervorzuheben, die zwischen verschiedenen Parasitenarten bestehen können. 
Um die Morphologie der Nahrungsvakuolen der phylogenetisch verwandten 
Parasiten P. vivax, P. knowlesi und P. cynomolgi mit P. falciparum zu 
vergleichen, ist eine Kombination von Färbetechnicken und ‘life-time’ konfokaler 
Mikroskopie verwendet worden, die die Expression von fluoreszierenden 
Fusionsproteinen innerhalb der Vakuole zeigt. Verschiedene Arten von 
Nahrungsvakuolen, die aktief Hämoglobin abbauen, waren in Parasiten vom 
‘vivax’-Typ zu beobachten, im Gegensatz zu einer einzigen, großen 
Nahrungsvakuole, die in P. falciparum zu sehen war. Zusätzlich ist 
Elektronenmikroskopie verwendet worden, um diese Studien zu ergänzen.  
PlasmepsinIV (PM4) ist eines der Schlüsselenzyme, die am Abbau von  
Hämoglobin beteiligt sind. Das pkpm4 Gen in P. knowlesi wurde so verändert, 
dass es eine Kopie von pkpm4 hervorbringt, die eine FKBP (‘FK506 binding 
protein’)-Destabilisierungsdomäne (DD) enthält. Dieses veränderte Gen kreiert 
Parasiten, die ein unstabiles PkPM4 Protein hervorbringen, das nur in Gegenwart 
von der Komponente Shield-1 stabil ist. In einem aminosäurelimitierenden 
Medium sind Parasiten abhängig von dem Abbau des Hämoglobins als 
Aminosauerequelle. In Abwesenheit von Shield-1 bleiben die Parasiten 
lebensfähig, aber ein aminosäurelimitierendes-Medium wirkt sich negativ sowohl 
auf das Aussehen wie auf das Wachstum der pkpm4DD Parasiten aus, während 
der Wildtyp P. knowlesi unberührt bleibt. Hiermit wird die Rolle des PKPM4 für 
den Aminosäureabbau unterstrichen Dies Resultat suggeriert aber auch, daß das 
Enzym nicht essentiell ist für die asexuelle Lebensfähigkeit des Parasiten. 
Die Nahrungsvakuole wird auch als Ziel für Chloroquine gesehen, ein 
Medikament, das viele Jahre lang erfolgreich eingesetzt wurde, um die 
menschliche Malaria zu behandeln. Durch das Entstehen von Resistenzen ist 
Chloroquine heutzutage weniger effizient in der Behandelung von Malaria 
verursacht durch P. falciparum. Mutationen in PfCRT, einem ‘channel-like’ 
Protein auf der Membran der Nahrungsvakuole sind in die Chloroquine-Resistenz 
bei P. falciparum verwickelt, obwohl keine Mutationen in dem homologen PvCRT 
Protein in resistenten P. vivax Parasiten identifiziert wurden, was auf einen 
Unterschied im Resistenz-Mechanismus der beiden Parasiten hinweist. Um zu 
bewerten, ob PfCRT fähig ist die Empfindlichkeit gegen das Medikament zu 
verändern, wurde ein Chloroquine-resistentes PfCRT Allel in P. knowlesi  
überexprimiert. Dieser Versuch resultierte in einer vierfach ansteigenden 
Toleranz gegen Chloroquine in einem Parasiten vom ‚vivax-Typ’, was darauf 
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hinweist, dass PfCRT fähig ist, die Chloroquine Toleranz in einem ‚non-
falciparum’ Parasiten zu modifizieren.  
Diese Studien zeigen die Bedeuting eines vielseitigen in vitro Kultur- und 
Transfektionssystems in einem Parasiten, der phylogenetisch nah verwandt ist 
mit dem zweitwichtigsten Malariaparasiten, und nutzen es um einige 
Hauptunterschiede hervorzuheben, die zwischen verschiedene Parasiten 
bestehen bezüglich der Zielorganelle für das Medikament. Forschung an 
fundamentalen biologischen Prozessen von P. knowlesi kann uns Einsichten 
verschaffen in die Biologie von ‚vivax-ähnlichen’ Parasiten und uns zudem ein 
unverzichtbares Hilfsmittel zur Verfügung stellen für Studien an Medikamenten 
und Impfstoffen. 
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Abbreviations 
°C degrees Celsius 
2D two dimensional 
3D three dimensional 
APAD 3-acetylpyridine adenine dinucleotide 
ATP adenosine triphosphate 
bp base pair 
cDNA complementary deoxy-ribonucleic acid 
CQR chloroquine resistant 
CQS chloroquine sensitive 
C-terminal carboxy-terminal 
D. discoideum Dictyostelium discoideum 
DD destabilisation domain 
DIC differential interference contrast 
DIG digoxygenin 
DNA deoxy-ribonucleic acid 
ef1α elongation factor 1 alpha 
EM electron microscopy 
ES early schizont 
FKBP FK506 binding protein 
FPIX ferric-protoporphyrin IX 
FRAP fluorescence recovery after photobleaching 
GFP green fluorescent protein 
h-dhfr human dihydrofolate reductase 
HDP Heme detoxification protein 
IC50 half maximal inhibitory concentration 
IFA immunofluorescence assay 
kb kilobase 
KO knock-out 
kV kilovolt 
l litre 
LS late schizont 
LS Blue LysoSensor Blue 
M molar 
MACS Magnetic cell separation 
mg milligram 
ml millilitre 
mM millimolar 
mRNA messenger ribonucleic acid 
NBF nitro blue formazan 
NBT nitro blue tetrazolium 
ng nanogram 
nM nanomolar 
OD optical density 
ORF open reading frame 
P. berghei Plasmodium berghei 
P. cynomolgi Plasmodium cynomolgi 
P. falciparum Plasmodium falciparum 
P. gallinaceum Plasmodium gallinaceum 
P. knowlesi Plasmodium knowlesi 
P. lophurae Plasmodium lophurae 
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P. malariae Plasmodium malariae 
P. ovale Plasmodium ovale 
P. vivax Plasmodium vivax 
PBS phosphate buffered saline 
Pc Plasmodium cynomolgi 
PCR Polymerase chain reaction 
Pf Plasmodium falciparum 
PfCRT P. falciparum chloroquine resistance transporter 
PfFP2 P. falciparum falcipain 2 
PfFP2’ P. falciparum falcipain 2’ 
PfFP3 P. falciparum falcipain 3 
PfHAP P. falciparum histo-aspartic protease 
PfHRPII P. falciparum histidine-rich protein II 
PfHRPIII P. falciparum histidine-rich protein III 
PfPM1 P. falciparum plasmepsin I 
PfPM2 P. falciparum plasmepsin II 
PfPM4 P. falciparum plasmepsin IV 
Pk Plasmodium knowlesi 
PkCRT P. knowlesi chloroquine resistance transporter 
pLDH Plasmodium lactate dehydrogenase 
Pv Plasmodium vivax 
PvCRT-o P. vivax chloroquine resistance transporter 
R ring 
RPMI-1640 Roswell Park Memorial Institute culture medium 
RPMI-1AA Amino-acid limited Roswell Park Memorial Institute culture 
medium 
RT reverse transcriptase 
SDS sodium dodecyl sulfate 
SSC sodium chloride-sodium citrate buffer 
T trophozoite 
tg-dhfr/ts Toxoplasma gondii dihydrofolate reductase thymidine synthase 
UTR untranslated region 
UV ultraviolet 
µF micro Faraday 
µg microgram 
µl microlitre 
µM micromolar 
µm micrometre 
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1. Introduction 
1.1 Malaria, a devastating human disease 
Malaria, caused by the protozoan parasite Plasmodium, is a disease which 
has plagued humanity throughout human history. The very earliest 
evidence of a Plasmodium parasite was found in a fossilized Culex 
mosquito in a piece of amber approximately 30 million years old (131). It 
has maintained a strong selective force on human evolution, evident from 
the presence of conditions such as sickle-cell disease, thalassaemias and 
glucose-6-dehydrogenase deficiency, conditions which persist due to the 
small reduction in susceptibility to malaria which they confer (91). 
References to the characteristic periodic fevers associated with malaria 
exist in many ancient Greek, Roman, Assyrian, Indian and Arabic 
writings, including the earliest from 5,000 years ago in the Chinese 
Huangdi Neijing (35), and evidence of malaria in ancient Egypt has been 
found with the identification of Plasmodium DNA in ancient Egyptian 
mummies (116). 
Today, 3.3 billion people live at risk of malaria infection. In 2008 
approximately 243 million cases resulted in almost 1 million deaths, 85% 
of which were children under the age of five, living in Sub-Saharan Africa 
(191). Malaria is predominantly a disease of the developing world, and its 
presence perpetuates the cycle of poverty. Illness and mortality due to 
malaria directly costs the African nations 12 billion US dollars per year 
and impedes the economic growth which could help these countries to 
eradicate the disease (60).  
These parasites have evolved clever strategies to evade the immune 
system, challenging vaccine development. The panel of antimalarial drugs 
is rapidly becoming less effective worldwide due to the appearance and 
dissemination of drug resistant strains. Therefore there is an urgent need 
to identify the unique aspects of the parasite biology in order to develop 
new drugs and an effective vaccine.  
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The four human Plasmodium species are P. falciparum, P. vivax, P. 
malariae and P. ovale. The primate malaria P. knowlesi is considered the 
“fifth human malaria” since it has recently emerged as the cause of a 
large number of malaria cases in South East Asia (182). P. falciparum is 
responsible for the most morbidity and accounts for 90% of the deaths 
attributed to malaria. P. falciparum is endemic in many tropical regions; 
throughout most of Sub-Saharan Africa, South and East Asia and South 
America (Fig. 1). P. vivax is the second most common cause of malaria 
and although it is less prevalent in Africa, it extends into many temperate 
areas in Asia and the Americas (Fig. 1). Plasmodium parasites have a 
complex life cycle with two hosts (Fig. 2). Transmitted to humans by the 
bite of a mosquito, the infection begins with an asymptomatic liver stage 
followed by the blood stages of the parasite which are responsible for the 
symptoms of the disease. Symptoms include the characteristic recurrent 
fevers, headaches, chills, joint pain, vomiting, anaemia, retinal damage 
and convulsions. The high mortality associated with P. falciparum 
infections is due to its ability to sequester in capillaries in major organs 
such as the brain, leading to damage, organ failure and death. 
  
Figure 1 Global 
distribution of malaria 
due to (a) P. 
falciparum and (b) P. 
vivax. Adapted from 
(67) . 
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Figure 2. Life cycle of the malaria parasite. Plasmodium parasites are transmitted 
by the Anopheles mosquito, which infects a human while feeding, injecting 
sporozoites into the blood stream with the mosquito saliva. The sporozoites travel to 
the liver, where they infect hepatocytes and over the course of 7-10 days the 
parasite undergoes a series of nuclear divisions within the hepatocyte, replicating 
thousands of merozoites (135) which escape from the liver cell into the blood 
stream where they each invade a red blood cell, commencing the symptomatic 
course of the disease. The parasite cycle within the red blood cell lasts for 
approximately 24-72 hours (depending on species) and during this time, the 
parasite replicates DNA and organelles to create 12-32 new merozoites which burst 
out of the infected cell and invade new red blood cells. A small number of parasites 
do not continue to replicate in the red blood cell, but develop into either male or 
female sexual stages known as micro- and macrogametocytes, respectively. These 
circulate in the blood where they can be taken up by an Anopheles mosquito during 
a blood meal on the infected human. Once in the mosquito mid-gut, a number of 
factors, such as the decrease in temperature and the presence of xanthurenic acid, 
trigger differentiation of the gametocytes to gametes (15). The male 
microgametocyte rapidly undergoes three rounds of nuclear division to form eight 
microgametes, each of which can fertilise a female macrogamete, forming a zygote. 
This zygote will undergo one round of mitosis followed by one round of meiosis to 
form an ookinete, which traverses the mosquito midgut wall and develops into an 
oocyst. Nuclear divisions within the oocyst lead to the formation of thousands of 
sporozoites which are released into the mosquito haemocoel and travel to the 
salivary glands where they remain until the mosquito’s next blood meal, infecting 
another human host, thus perpetuating the cycle (30). (Adapted from 
http://www.dpd.cdc.gov/dpdx) 
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1.2 Plasmodium vivax: A benign malaria? 
P. vivax is traditionally known as the “benign” malaria due to the lower 
mortality compared to P. falciparum. As a result P. vivax has received less 
attention from policy makers and researchers in the attempt to eradicate 
malaria. Recently however, this view of P. vivax has been shifted to the 
realisation that this parasite is responsible for a serious disease that has 
been severely underestimated (111, 134). Due to its wide geographical 
distribution, P. vivax threatens 2.6 billion people (67) and estimates for 
the annual number of P. vivax infections range from 80 to a couple of 
hundred million (69, 134). These figures may even be underestimated 
due to inaccurate diagnosis of low level or mixed infections with light 
microscopy. The rapid diagnostic tests which are currently available may 
be  unreliable in detecting low parasitaemias and cannot distinguish 
between Plasmodium species (190).  Due to low transmission rates in P. 
vivax risk areas, protective immunity is rare and the disease affects all 
ages. Uncomplicated infections of P. vivax cause agonising disease which 
can persist for months if left untreated. In addition to acute episodes of 
high fevers, reports of severe disease attributed to monoinfection with P. 
vivax included cerebral malaria with seizures, hepatic dysfunction, lung 
injury with acute respiratory distress syndrome, renal failure, retinal 
haemorrhage, splenic rupture and severe anaemia (8, 96).  
 
There are a number of features of P. vivax biology which must be 
considered if worldwide malaria eradication efforts are to be successful. 
The merozoites of P. vivax have a preference for infecting reticulocytes, 
immature forms of erythrocytes, which leads to severe anaemia despite 
relatively low parasitaemia. 
P. vivax invades the red blood cell through interaction with the Duffy 
antigen on the surface of red blood cell, considered to be the only 
mechanism for invasion for P. vivax. A high proportion of the population 
of sub Saharan Africa are Duffy antigen negative and therefore P. vivax is 
 16 
not common in these regions. However some recent reports suggest that 
P. vivax has infected Duffy negative individuals in Kenya and Brazil (25, 
145) with confirmed P. vivax cases in Duffy negative individuals in 
Madagascar (110). If P. vivax evolves a new invasion mechanism which 
allows it to efficiently infect Duffy negative erythrocytes, it could quickly 
spread through Africa, creating a serious set-back for eradication efforts. 
All blood stages of P. vivax can be found in the circulation of an infected 
patient. The parasite does not form “knobs” on the surface of the infected 
red blood cell and can therefore not adhere to endothelial cells and 
sequester in organs in a similar manner to P. falciparum. There have 
been reports of P. vivax-mediated damage due to apparent sequestration 
of the parasites in the lungs and spleen (6, 42). Given the inability of P. 
vivax to adhere to endothelial cells and sequester in the same manner as 
P. falciparum, these severe symptoms may be a result of a large 
inflammatory imbalance caused by P. vivax (5, 71). 
Gametocytes of P. falciparum do not appear in circulation until seven to 
15 days after the first blood stage cycle but gametocytes of P. vivax can 
appear in the peripheral blood of an infected individual even before the 
onset of clinical symptoms (111, 133). This means that an individual has 
the potential to transmit the parasite to a mosquito before realising that 
they are even infected.  
 
The most exceptional feature of P. vivax is the parasite’s ability to cause 
relapse weeks, months or years after the intial infection (87). This is due 
to the formation of dormant stages called hypnozoites in the liver of the 
host. A number of sporozoites do not develop immediately into schizonts 
once they have invaded the hepatocyte. They can remain dormant in the 
liver cell for many weeks before, due to unknown cues, they activate, 
replicating new merozoites and causing another blood infection (31). 
Strains of P. vivax from temperate regions tend to form more hypnozoites 
and remain dormant for longer than strains of P. vivax from tropical 
regions. This allows the parasite to survive periods of the year, such as 
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winter, when transmission is not possible due to the absence of the 
mosquito vector (10, 75). Primaquine is the only compound in clinical use 
which is effective against hypnozoites and thus prevent relapse of P. 
vivax. However, its mechanism of action is unknown, there are toxicity 
issues with the use of this drug, particularly in individuals with glucose-6-
phosphate dehydrogenase deficiency where primaquine causes acute 
haemolysis and resistance to this drug may already have appeared (10). 
Hypnozoites represent a serious hurdle in the effort to eliminate malaria, 
primaquine will not be sufficient to address this issue, therefore efforts 
are underway to produce a ‘radical cure’ for P. vivax, which can purge the 
hypnozoites from the liver and prevent relapse (188). 
1.3 Antimalarial drugs and the emergence of drug resistance 
One of the major obstacles in the fight against malaria is the emergence 
and spread of P. falciparum strains resistant to all compounds in clinical 
use. A number of compounds are currently in clinical development, but 
the majority of these are derivatives of existing antimalarial drugs, or 
novel compounds in combination with an existing antimalarial (187), 
which could limit the efficacy of these treatments due to pre-existing, 
resistance-conferring mutations. This necessitates an understanding of 
drug resistance in the Plasmodium parasites in order to develop strategies 
to combat the onset of resistance and maximise the length of time these 
treatments remain effective. 
The discovery of chloroquine for the treatment of malaria was hailed as 
the weapon which signified victory over the Plasmodium parasite, but the 
dissemination of chloroquine resistant parasites has rendered the drug all 
but useless. Extensive research is ongoing to understand the mechanism 
which parasites have developed to negate the drugs effect. 
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1.3.1. Chloroquine: mode of action and mechanisms of resistance 
Chloroquine was once the wonder drug in the fight against malaria. 
Introduced in the 1940’s, it was cheap to produce, was effective against 
the parasite blood stages and was associated with good tolerability and 
low toxicity. Extensive use of the drug worldwide led to the appearance of 
chloroquine resistant (CQR) P. falciparum in the 1950’s in Thailand and 
Colombia, in the 1960’s in Papua New Guinea and spreading to Africa by 
the 1970’s (126, 185). Interestingly, CQR P. vivax did not emerge until 
the late 1980’s in New Guinea but has since spread through parts of 
Central America, South East Asia and Africa (9). This surge in chloroquine 
resistance and the lack of convenient alternatives to chloroquine has led 
to a rise in the morbidity and mortality due to P. falciparum, particularly 
in Africa (177). 
Chloroquine accumulates in the food vacuole of Plasmodium parasites and 
interferes with the crystallisation of haem into haemozoin (57). 
Chloroquine in its uncharged state is membrane permeable and 
distributes throughout the parasite, however once the drug enters the 
acidic environment of the food vacuole, it becomes trapped in its 
positively charged, membrane-impermeable form and accumulates to a 
concentration up to 20,000 times higher than the extracellular medium 
(147, 194). The protonated chloroquine molecule then forms complexes 
with haem, preventing the formation of beta-haematin dimers and their 
incorporation into haemozoin, leading to accumulation of toxic haem and 
death of the parasite (28, 57, 161, 173). Binding of chloroquine to haem 
may also account for a significant proportion of chloroquine accumulation 
in the Plasmodium food vacuole (20, 21). The basis of chloroquine 
resistance appears to be a reduction of levels of the drug at its site of 
action (21). CQR P. falciparum parasites accumulate four to ten times less 
chloroquine in the food vacuole than chloroquine sensitive (CQS) 
parasites (147). The presence of the calcium channel blocker verapamil 
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negates the resistance mechanism, restoring the response of CQR 
parasites to that of CQS (86, 107). 
1.3.2. pH dependent changes 
Initially it was proposed that the reduced accumulation of chloroquine in 
the food vacuole of CQR parasites was due to an increase in pH in the 
food vacuole (194). Considering the nature of the chloroquine molecule 
and according to weak-base theory, a higher food vacuole pH would result 
in lower accumulation of chloroquine (194). Two different methods were 
used by one group to measure the pH of food vacuoles in both CQS and 
CQR parasites: acridine orange or dextran-tagged probes. These studies 
suggested that food vacuole pH was in fact lower in CQR parasites 
compared to CQS parasites, which according to the Henderson-
Hasselbalch equation, should result in increased chloroquine 
accumulation. (50, 178). They reasoned that a more acidic pH altered 
haem polymerisation kinetics; increasing the rate of haemozoin formation 
thereby decreasing the amount of haem available for chloroquine binding. 
The methods used in these studies have been called into question, due to 
the accumulation of acridine orange in compartments of the parasite 
other than the food vacuole and the buffering capabilities of the probes 
used which could alter food vacuolar pH (167), as well as the high 
sensitivity of the food vacuole to laser illumination during microscopic 
analysis (192). Two subsequent investigations, using either pH-sensitive 
fluorescent protein (89) or dextran-linked, pH-sensitive fluorescent dyes 
(70) have not found any difference in food vacuole pH between CQS and 
CQR parasites. Furthermore the structurally related quinoline 
antimalarials such as mefloquine and quinine are also amphipathic weak 
bases and if a change in pH was the determining factor in chloroquine 
resistance, then an altered pH would also modulate the response of the 
parasite to these drugs (167). On the contrary, CQR P. falciparum is often 
more susceptible to these drugs (22). It has become clear that while 
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modulation of pH in CQR may be a factor in determining chloroquine 
senstivity, it does not play a significant role. 
1.3.3. PfCRT: Chloroquine transporter 
The hypothesis that chloroquine is being transported out of the food 
vacuole by a carrier or transporter in CQR parasites, has been bolstered 
by a number of recent studies. A large body of evidence has been 
collected to implicate PfCRT as a facilitator of chloroquine transport across 
the food vacuole membrane and there remains little doubt that it forms a 
channel or pore through which, when the necessary mutations are 
present, chloroquine can pass. 
A genetic cross between a CQS line and a CQR line of P. falciparum 
identified a single locus associated with inherited chloroquine resistance of 
36kb on chromosome 7 (168, 186). Further investigations led to the 
identification of pfcrt, a 13 exon gene, predicted to code for a 424 amino 
acid protein with ten predicted transmembrane domains (56, 118). The 
protein encoded by pfcrt was expressed in asexual blood stages and was 
found to be localised to the food vacuole membrane (33, 56). The critical 
mutation which confers chloroquine resistance is the replacement of a 
lysine(K) at position 76 with a threonine(T) (43, 92) which is located in a 
predicted transmembrane region implicated in substrate recognition 
(105). The K76T mutation is ubiquitous in CQR parasites (43, 129). 
Accessory mutations in a further 14 positions always found in addition to 
K76T, depend on the geographical origin of the P. falciparum isolate and 
are expected to compensate for the K76T effect on the function of PfCRT 
(19). These additional mutations appear to also play a role in modulating 
the parasite response to other antimalarials (34). Allelic exchange 
experiments demonstrated that CQR alleles introduced into CQS parasites 
increased the IC50 of those parasites to chloroquine, which was verapamil 
reversible (157).  
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Although the endogenous function of PfCRT has not yet been defined, it 
has been identified as a member of the drug-metabolite transporter 
(DMT) superfamily, closely related to transporter proteins in 
Cryptosporidium parvum and Dictyostelium discoideum (105, 176). Plant 
homologs of PfCRT identified in Arabidopsis are located in the plastid and 
were shown to be involved in regulating glutathione levels in the plant cell 
cytosol (108).  
Heterologous expression systems have proved useful in determining the 
role PfCRT plays in chloroquine transport. Recombinant PfCRT expressed 
in the yeast Pichia pastoris was shown to bind chloroquine (196) and 
when reconstituted into proteolipsomes was shown to increase 
chloroquine transport (174). Heterologous expression of PfCRT in the 
slime mould Dictyostelium discoideum demonstrated that mutant PfCRT 
which localised to the acidic endosomes, could expel chloroquine from 
these compartments (114). It was also noted in this study that the 
mutant form of PfCRT expressed in D. discoideum was associated a slight 
increase in endosomal pH, lending some support to the theory that 
modulation of pH may be important in chloroquine resistance (114). 
Mutant PfCRT expressed in the plasma membrane of Xenopus laevis 
oocytes transports chloroquine with higher efficiency than the wild type 
PfCRT (106). 
The importance of the K76T mutation appears to be due to the charge 
within the channel. The change from positive (lysine) to neutral 
(threonine) allows the protonated chloroquine access to the channel. 
Verapamil may bind within the channel, restoring a net positive charge 
which repels the positively charged chloroquine (34). This has prompted a 
number of hypotheses to describe how PfCRT alters the accumulation of 
chloroquine in the CQR food vacuole, whether chloroquine travels through 
the channel in a passive, energy-independent process, or if PfCRT actively 
effluxes chloroquine out of the cell (20, 151).  
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1.3.4. Passive transport of chloroquine 
PfCRT may function as a ‘voltage-gated channel’ where under energised 
conditions, the channel is open and allows the passive flow of chloroquine 
down its concentration gradient, out of the food vacuole and into the 
parasite cytoplasm (20). When the energy supply is removed or the 
proton gradient is reduced, the channel closes and blocks the flow of 
chloroquine out of the food vacuole (20). PfCRT has a degree of similarity 
to calcium chloride channels from a number of different organisms (183) 
and when PfCRT was expressed in P. pastoris and reconstituted into 
vesicles, it was responsible for a chloride-dependent decrease in pH inside 
the vesicles (196). 
1.3.5. Active transport of chloroquine 
An energy-dependent efflux was first suggested as the basis for 
chloroquine resistance when it was reported that addition of glucose to 
the medium of CQR parasites resulted in a decrease of chloroquine 
accumulation in the food vacuole while in contrast, additional glucose 
caused increased chloroquine accumulation in the food vacuole of CQS 
parasites (85, 86). This theory was further supported when it was 
demonstrated that this decrease in chloroquine accumulation in CQR 
parasites coincided with ATP production (150). This study also observed 
that chloroquine accumulation occurred in a trans-stimulated manner, 
where preloaded unlabelled chloroquine in the food vacuole of CQR, but 
not CQS parasites, stimulated the uptake of labelled chloroquine in the 
extracellular medium (150). Trans-stimulation is indicative of an active 
efflux mechanism rather than a passive diffusion, since movement of 
substrate through a channel in different directions blocks movement 
rather than enhances it. Trans-stimulated chloroquine efflux was 
demonstrated in both CQR and CQS parasites, where unlabelled 
chloroquine in the extracellular medium enhanced labelled chloroquine 
transport out of the food vacuole (149). In the presence of metabolic 
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energy, CQR parasites demonstrated a much higher chloroquine efflux 
rate than CQS parasites, which was verapamil sensitive (149). These 
transport kinetics were directly linked to the K76T mutation, which the 
authors proposed may allow binding of chloroquine to the carrier or 
alternatively facilitate coupling of chloroquine efflux to the proton-motive 
force (149). 
1.3.6. Chloroquine resistance in P. vivax 
CQR P. vivax was first detected in Papua New Guinea in 1989 (136), has 
spread throughout the Indonesian archipelago and appears to be 
expanding through South East Asia and South America (9, 111, 133). 
Chloroquine resistance took only ten years to appear in P. falciparum in a 
number of independent locations but chloroquine resistance strains of P. 
vivax did not appear for almost 40 years after introduction of the drug, 
despite heavy use throughout all endemic regions. One reason why 
chloroquine resistance took longer to appear in P. vivax may relate to 
differences in gametocytogenesis between P. vivax and P. falciparum. As 
mentioned previously, P. vivax gametocytes appear in the circulation of 
an infected individual very early in the course of the disease, meaning 
that the parasites can be transmitted prior to drug selection, reducing the 
selection pressure of chloroquine on resistant mutations. However, a 
limited number of studies suggest that chloroquine inhibits transmission 
of P. vivax gametocytes but not P. falciparum gametocytes (9, 23), which 
would serve to enhance the spread of chloroquine resistant P. vivax. 
In P. falciparum chloroquine resistance can be diagnosed on recurrence of 
parasites in circulation following chloroquine treatment. Distinguishing 
between parasites present as a result of a recrudescence or reinfection 
can be done through genotyping. Characterisation of chloroquine 
resistance in P. vivax presents a challenge since reappearance of P. vivax 
parasites may be due to recrudescence, reinfection or relapse due to 
hypnozoite activation. For P. falciparum the only source of new infections 
 24 
is from an infected mosquito bite, while new infections of P. vivax may be 
a result of an infected mosquito bite but also reactivation of a hypnozoite 
in the patients liver. Treatment efficacy is therefore evaluated based on 
plasma drug concentrations and the timing of recurrences (9). Treatment 
is deemed a failure due to chloroquine resistance if parasites reappear in 
circulation within 28 days of commencing treatment and if the whole 
blood concentration of chloroquine and desethylchloroquine (the major 
metabolite of chloroquine) of the patient on the day of parasite recurrence 
is 100ng/ml or greater (11). 
Ex vivo assays also provide a practical means of assessing the response 
of P. vivax isolates to chloroquine, allowing objective comparison of 
chloroquine sensitivities of different isolates. Parasites are removed from 
the patient and after short-term culture in vitro in the presence of 
chloroquine, the parasite number is evaluated by either parasite lactate 
dehydrogenase assay, [3H]hypoxanthine incorporation or microscopic 
examination (48, 144). The asynchronous nature of P. vivax infections 
means that the in vitro drug response of an isolate must be interpreted in 
light of the initial stage of the parasites and the duration of the assay. A 
further complication which has been recently highlighted by such ex vivo 
studies on P. vivax isolates is that P. vivax trophozoites appear to be 
intrinsically insensitive to chloroquine, in sharp contrast to P. falciparum 
(143, 154). 
To date, no molecular markers have been found to correlate with 
chloroquine treatment failure in P. vivax. The P. vivax ortholog of PfCRT, 
PvCRT-o does not have any polymorphisms which are associated with 
increased resistance to chloroquine (9, 118). Heterologous 
overexpression of PvCRT-o in a CQS strain of P. falciparum increased the 
IC50 2.2-fold (146). Expression of PvCRT-o in the slime mould 
Dictyostelium discoideum demonstrated reduced chloroquine 
accumulation in acidic endosomes in a verapamil-reversible manner 
(146). An engineered PvCRT-o sequence, which contained the K76T 
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mutation characteristic of CQR in P. falciparum, expressed in D. 
discoideum was also able to reduce chloroquine accumulation (146). This 
study serves only to demonstrate that PvCRT-o is capable of chloroquine 
transport, but considering the dearth of pvcrt mutations in CQR P. vivax, 
does not implicate PvCRT in chloroquine resistance in P. vivax.  
These features of chloroquine effect and resistance in P. vivax warrant  
investigation into the presumed target of chloroquine, the food vacuole 
and characterisation of this organelle with respect to species specific 
differences which may highlight alternative modes of drug action. 
1.4 The Plasmodium food vacuole: Haemoglobin uptake and 
degradation 
During the asexual cycle in the erythrocyte, Plasmodium parasites ingest 
approximately 75% of the host cell cytoplasm, which is rich in 
haemoglobin (65). The ingested haemoglobin is transported to a 
specialized lysosome-like organelle called the food vacuole, or digestive 
vacuole, where is it degraded by a series of proteases, generating amino 
acids and haem, the iron-containing moiety of haemoglobin (65).  
The most obvious function of haemoglobin degradation is to provide an 
amino acid source for the parasite, and indeed, labelled amino acids from 
haemoglobin are incorporated into P. falciparum protein (109, 156). 
However, haemoglobin is a poor source of methionine, cysteine, 
glutamine and glutamate and does not contain any isoleucine. Due to the 
parasite’s limited ability for de novo amino acid synthesis (155, 175), it 
must rely on an exogenous source for these amino acids, particularly 
isoleucine. This is indeed the case; P. falciparum can grow well in medium 
containing only isoleucine, but these parasites have a much increased 
sensitivity to protease inhibitors, highlighting their dependence on 
haemoglobin degradation as a source of amino acids when amino acids in 
the medium are scarce (104). Naughton et al. have demonstrated that 
the inhibition of parasite growth when haemoglobin degradation is 
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blocked (by plasmepsin and falcipain inhibitors) is due to a block in 
protein synthesis (115). 
However, not all the amino acids liberated from haemoglobin proteolysis 
are incorporated into protein. The parasite ingests ten times the amount 
of haemoglobin protein than it utilises as amino acids even in amino acid 
rich medium (88) indicating haemoglobin digestion is not only necessary 
for a source of amino acids. Some hypotheses propose that the parasite 
digests haemoglobin to make room to grow within the host cell (62), to 
maintain osmotic balance (97) and may use the amino acids as an energy 
source (155). The parasite may also use some of the liberated haem as 
an iron source (153). 
Regardless of the primary role of haemoglobin degradation in the 
parasite, there is no doubt that this process is essential; if proteolysis of 
haemoglobin is blocked using protease inhibitors, parasite development is 
interrupted (59, 101, 104, 137-140) 
1.4.1 Haemoglobin uptake and food vacuole formation 
Early electron microscopy (EM) work on the feeding process of a number 
of Plasmodium species identified vesicles containing haemoglobin which 
orginate from double membraned endocytic invaginations on the parasite 
cell surface (141). These morpholgically distinct invaginations were 
termed “cytostomes” and appeared to become most active at the 
trophozoite stage (2). Further EM studies on P. falciparum extended this 
model to describe transport of the cytostomal-derived vesicles to the food 
vacuole where haemoglobin digestion takes place (162). An additional 
mechanism was observed which occurs in ring stages whereby small 
volumes of host cell cytosol were endocytosed by an cytostomal-
independent process termed micropinocytosis (162). Haemoglobin 
degradation appeared to take place in these small vacuoles, as small 
crystals of haemozoin were visible before fusion of the vesicle to the main 
food vacuole (162). 
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Recently, improved imaging and molecular techniques have allowed more 
extensive study on this process in P. falciparum but has led to conflicting 
theories. Elliott et al. reported four different haemoglobin uptake 
mechanisms in P. falciparum. They proposed that a large phagocytic 
event in the ring stages, termed the “Big Gulp”, leads to the formation of 
the food vacuole. Three additional uptake mechanisms are then 
responsible for the transport of haemoglobin to this compartment for 
processing. They described micropinocytosis events occurring throughout 
the cycle and phagotrophic vesicles which are formed only at the schizont 
stages (53). Cytostomal uptake had previously been perceived as the 
major contributor to haemoglobin uptake in P. falciparum, surprisingly 
however, this study claims that this process occurs only for a short period 
in trophozoites and is not responsible for the bulk of haemoglobin uptake 
(53). An independent study also using serial-section electron microscopy 
proposed a vesicle-independent mechanism of haemoglobin uptake 
whereby the cytostome invagination opposes the food vacuole and 
haemoglobin vesicles bud from the cytostomal tube directly into the food 
vacuole (94). However, results from other groups using methods 
complementary to EM agree with the model intially proposed by 
Slomianny (162) in which endocytosis of haemoglobin in P. falciparum 
commences in the mid ring stage via micropinocytosis, forming small 
haemoglobin containing vesicles which coalesce to form the food vacuole. 
The bulk of haemoglobin uptake subsequently occurs via the cytostome 
forming vesicles which are transported to the food vacuole for 
haemoglobin degradation (1, 44, 165). 
It remains unclear if the haemoglobin containing vesicles derived from 
two different uptake pathways have different properties/capacities for 
haemoglobin degradation. Microcrystals of haemozoin have been 
observed in small vacuoles which appear to be derived from pinocytosis 
(44, 93, 119, 162). However, in larger vacuoles which are derived from 
the cytostome haemoglobin processing does not take place until reaching 
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the food vacuole. Furthermore, single membraned vesicles which contain 
haemoglobin have also been observed in the food vacuole, suggesting 
that for many vesicles degradation does not take place until delivery to 
the food vacuole (195). 
Actin has been implicated at a number of points of the haemoglobin 
uptake process. Treatment of P. falciparum with actin inhibitors decreased 
cytostome number and impaired (but did not completely block) cytostome 
development (94). Actin inhibitors were also reported to cause the 
accumulation of undigested haemoglobin in the parasite, suggesting that 
actin is also required for transport of haemoglobin to the food vacuole, 
fusion of vesicles with the food vacuole or transport of proteolytic 
enzymes to the food vacuole (53, 165). 
1.4.2 Haemoglobin degradation pathway in Plasmodium 
The food vacuole contains a number of different types of proteases which 
are responsible for cleavage of the haemoglobin, to produce short 
peptides or amino acids which can then be transported out of the food 
vacuole to be incorporated into parasite protein or to be excreted. The 
different proteases which have been localised to the food vacuole and are 
probably involved in this process in P. falciparum include aspartic 
proteases called plasmepsins, cysteine proteases called falcipains, a 
metalloprotease called falcilysin and at least one dipeptidylpeptidase. 
Aminopeptidases must be involved but to date it is unclear if they are 
active in the food vacuole or in the cytoplasm.  
Haemoglobin is degraded in a ordered process in which the plasmepsins 
make the initial cleavage of haemoglobin, making available cleavage sites 
for the falcipains and subsequently falcilysin, dipeptide aminopeptidases 
and aminopeptidases (65).  
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1.4.2.1 Aspartic proteases - plasmepsins 
Four of the ten aspartic proteases, or “plasmepsins” in the P. falciparum 
genome are localised to the food vacuole, PfPM1, PfPM2, PfPM4 and PfHAP 
(histo-aspartic protease).  All four genes are located at a single locus on 
chromosome 14 and appear to be products of a duplication event at some 
stage in the evolution of P. falciparum and P. reichenowi, since all other 
Plasmodium species sequenced to date have only one plasmepsin gene, 
an ortholog of PfPM4 (40). Transcripts for PfPM1 and PfPM4 peak early in 
the intraerythrocytic cycle while transcripts for PfPM2 and PfHAP peak in 
the latter part of the cycle, suggesting that these proteases function in 
specific roles at distinct stages of the asexual cycle (18, 95).  
The substrate specificities of these enzymes indicate that they are 
responsible for the initial cleavage of native haemoglobin at position 
33Phe-34Leu, which unravels the molecule and makes other sites 
available for processing by plasmepsins and other downstream enzymes 
(64, 66, 189, 193). The isoelectric points of the active plasmepsins (pH 4-
5) are consistent with their role in the food vacuole (40). 
Different parasite lines have been generated with single plasmepsin knock 
outs and in which different combinations of plasmepsins have been 
knocked out (16, 17, 103, 120). These knock out parasites had growth 
rates comparable to that of the parental strain except for a line in which 
pm4 had been knocked out suggesting that this enzyme plays the most 
important role in haemoglobin digestion (103, 120). A triple knock out 
(pfpm1, pfpm2 and pfhap) and even a quadruple knockout of all four 
plasmepsins was achieved, yielding viable parasites which had slightly 
slower growth rate than that of the parental strain in complete medium 
and produced slightly less haemozoin, clearly due to less efficient 
haemoglobin processing (16). This parasite line could not survive on 
amino acid limited medium, underlining its dependence on an exogenous 
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source of amino acids when the haemoglobin degradation process is 
impaired (16). 
The intracellular targeting of PfPM2 has been studied in detail in P. 
falciparum. It is trafficked through the endoplasmic reticulum to the 
plasma membrane as a Type II membrane protein where it localises at 
the cytostome. The protein remains associated to the membrane until a 
cargo of host cell cytosol has been endocytosed and it is transported to 
the food vacuole in the endosome along with the haemoglobin (77). The 
P. falciparum plasmepsins are activated by cleavage at a processing site, 
conserved in all four proteins (124Gly-125Ser), to release the active 
enzyme into the lumen of the food vacuole. This activation step appears 
to be carried out by a falcipain, another food vacuole protease, although 
in the absence of a falcipain, the plasmepsins have a less efficient 
autocatalytic function (47).  
1.4.2.2 Cysteine proteases – falcipains and vivapains 
There are three cysteine proteases involved in haemoglobin digestion in 
P. falciparum, known as the falcipains: PfFP2, PfFP2’ and PfFP3. All three 
have been localised to the food vacuole (38). Although all they share a 
high degree of identity, PfFP2 expression peaks earlier in the asexual 
cycle in early trophozoites, with FP2’ and FP3 peaking in expression levels 
in late trophozoites and early schizonts (38). A bi-partite trafficking signal 
mediates correct targeting of the falcipains to the food vacuole. Two 
amino acids stretches, 16-25 in the cytoplasmic portion of the protein and 
84-105 in the luminal domain, target the protein from the endoplasmic 
reticulum, through the Golgi to the plasma membrane and subsequent 
transport to the food vacuole in the cytostome-derived transport vesicles 
(170). 
Falcipain-2 knock out parasites accumulate undigested haemoglobin in 
the food vacuole at the trophozoites stage, but this phenotype disappears 
by the schizont stage, presumably due to compensation by expression of 
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falcipain-2’ and falcipain-3 later in the asexual cycle (159). Falcipain-3 
could not be knocked out indicating an essential role for this enzyme 
(158). 
Falcipain-2 and falcipain-3 do not appear to have a specific cleavage site 
in haemoglobin but display preference for smaller peptides with a leucine 
residue at position P2 of the cleavage site (169). This suggests that the 
falcipains are responsible for the bulk of haemoglobin hydrolysis, rapidly 
cleaving the molecule at multiple sites (169). Although the role of the 
plasmepsins in this process may not be essential, initial cleavage and 
unravelling of the haemoglobin molecule by the plasmepsins probably 
optimises the degradation process. 
Orthologs of falcipains in P. vivax, the “vivapains” have similar but not 
identical substrate and inhibitor specificities to the P. falciparum falcipains 
(113). Vivapain-2 and vivapain-3 both hydrolyse haemoglobin at low pH 
although the pH optimum of vivapain-2 is less acidic and the enzyme 
appears to be more stable at neutral pH than vivapain-3 (113), 
suggesting that vivapain-2 plays a role in degradation of erythrocytic 
cytoskeletal components, similarly to falcipain-2 (49, 68). 
 
1.4.2.3 Falcilysin 
 
The peptides resulting from plasmepsin and falcipain action on 
haemoglobin are further processed by falcilysin. Falcilysin is a member 
of the M16 family of zinc metalloproteases and is localised to the food 
vacuole in P. falciparum (51). In acidic conditions similar to the 
Plasmodium food vacuole (pH 5.2), falcilysin has a preference for 
converting short polypeptides (approx. 20 amino acids) into 
oligopeptides of 5-10 amino acids. At neutral pH however, falcilysin 
more efficiently cleaves peptides rich in positively charged residues 
(112). Falcilysin has also been found to localise to the apicoplast and to 
a lesser extent, the mitochondria, where it is probably involved in 
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cleaving the targeting peptides of proteins trafficked to these 
organelles (132).  
 
1.4.2.4. Processing of oligopeptides to dipeptides and amino 
acids 
 
The dipeptidyl aminopeptidase DPAP1 is a cathepsin C homolog which 
was localised to the food vacuole in P. falciparum and releases 
dipeptides from the N-termini of haemoglobin-derived peptides (78). 
It is unclear if terminal processing of short peptides/dipeptides to 
single amino acids takes place in the food vacuole or in the cytoplasm 
of the Plasmodium parasite. Two amino peptidases PfA-M1 and PfAPP 
were localised to the food vacuole in P. falciparum (39), however 
processing of haemoglobin oligopeptides by food vacuole extracts failed 
to yield any free amino acids (84). Aminopeptidase activity in the 
cytosol of the parasite has been demonstrated to degrade haemoglobin 
peptides (61) and a zinc aminopeptidase has been localised to a region 
in the parasite cytoplasm closely associated with the food vacuole 
membrane (4). It is possible that the final processing to amino acids 
takes place in both locations, depending on the availability and 
specificity of dipeptide and amino acids transporters which are present 
on the Plasmodium food vacuole membrane. 
 
There is enormous redundancy within this degradative pathway in P. 
falciparum. Duplications have given rise to four plasmepsins, while 
other Plasmodium species express only one (40). The parasite is still 
viable in the absence of any of its plasmepsins and retains the capacity 
to degrade haemoglobin and produce haemozoin, relying on the three 
falcipains to compensate (16). There is an additional degree of 
redundancy in the processing of the proplasmepsins, they demonstrate 
autocatalytic activity in the absence of the falcipains (47). This 
redundancy presents a greater challenge to the development of 
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compounds which inhibit this process, but underlines the importance of 
this pathway to the parasite. The parasite simultaneously facilitates the 
formation of haemozoin from haem, another unique process which 
provides an opportunity for antimalarial development. 
 
1.4.3 Haemozoin formation 
A by-product of the proteolysis of haemoglobin is ferrous-protoporphryin 
IX, the iron-containing moiety of haemoglobin, which is rapidly oxidised 
to ferric-protoporphryin IX (FPIX) in the acidic environment of the food 
vacuole. FPIX or haem, is highly toxic to the parasite. At low 
concentrations (10-20µM), it is known to inhibit the plasmepsins and 
falcipains in the digestive vacuole (64, 181) as well as cytosolic enzymes 
such as glyceraldehyde-3-phosphate dehydrogenase and 6-
phosphogluconate dehydrogenase (24, 55). FPIX production also 
generates highly reactive species such as hydrogen peroxide, superoxide 
radicals and the hydroxyl radical which mediate peroxidation of 
membrane lipids (13, 26, 79). In addition, haem is much more soluble in 
lipid than in water and can incorporate into the membrane, destabilising it 
(102) and making it more susceptible to hydrogen peroxide mediated 
lysis (29, 58, 121). 
In order to prevent haem-mediated lysis, the parasite must abolish the 
toxic effects of the haem molecule. To this end, the parasite incorporates 
the haem into inert haemozoin, a dense crystalline substance which is 
visible by microscopic examination in the food vacuole of the parasite. 
This process in which Plasmodium forms crystals from large organic 
molecules is termed biocrystallisation (72) and represents a very efficient 
means of detoxification. Two haem molecules are covalently linked by an 
iron-carboxylate bond to form a β-haematin dimer which is then 
incorporated into the crystal lattice through hydrogen bonding (122). The 
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crystal is extended by continued incorporation of β-haematin dimers into 
the lattice. 
1.4.3.1 Haemozoin formation: Protein or lipid mediated? 
Given the hydrophobicity of haem, it seems logical that lipids may play an 
important role in initiating haemozoin formation and a number of studies 
support this theory (14, 45, 46). 
Hempelmann et al. proposed that membrane lipids derived from the 
parasitophorous vacuole membrane transported along with the 
haemoglobin to the food vacuole may provide a scaffold for the 
developing crystal. The membrane lipid within the aqueous environment 
of the food vacuole could concentrate the hydrophobic haem and provide 
a nucleation centre for the β-haematin dimers (73). Pisciotta et al. 
observed that haemozoin crystals in P. falciparum were contained within 
“neutral lipid nanospheres” composed of mono- and diacyl glycerols in the 
food vacuole. They hypothesised that it is these neutral lipids which 
provide a hydrophobic environment that promotes formation of β-
haematin dimers in the food vacuole (130). 
The role of a protein in haemozoin formation was indicated by the ability 
of extracts of Plasmodium trophozoites to form β-haematin (161). The P. 
falciparum histidine rich proteins II and III (PfHRPII and PfHRPIII), the 
first candidates proposed for this role, were shown to bind haem and 
promote haemozoin formation (27, 152, 172) but lack of orthologs in 
other Plasmodium species (171) and the discovery of a P. falciparum lab 
clone which lacked both hrpII and hrpIII but was still able to produce 
haemozoin supported theories of lipid mediated haemozoin formation 
(117). 
The Heme Detoxification Protein (HDP) has recently been identified as 
having haem binding properties and a very efficient mediator of 
haemozoin formation in vitro. The gene is very highly conserved across all 
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Plasmodium species sequenced to date and was not amenable to genetic 
disruption, suggesting an essential function for the protein. HDP was 
found to be localised to both the food vacuole of P. falciparum as well as 
the host cell cytoplasm and the investigators of the study proposed that 
the protein is secreted into the host cell and is then internalised along 
with the host cell cytoplasm by the cytostome and trafficked to the food 
vacuole (76). 
This evidence suggests that haemozoin formation in the Plasmodium food 
vacuole occurs within lipid droplets where parasite proteins such as HDP 
may play a role in binding haem to chaperone or deliver it to the lipid 
spheres. 
The unique nature of the Plasmodium food vacuole and the biochemical 
pathways involved in haemoglobin breakdown and subsequent haemozoin 
formation identifies it as an important target for new antimalarial 
compounds. Knowledge of this organelle in only one of the Plasmodium 
species may hinder the development of compounds effective against all 
species which cause malaria in man. At the very least, it must be a 
priority to characterise the food vacuole of the other Plasmodium parasite 
which is a major cause of human malaria, P. vivax. 
1.5 P. knowlesi: a versatile model for P. vivax  
Extensive cellular and molecular studies on the erythrocytic stages of  P. 
vivax have been hindered due to the parasites narrow host cell specificity. 
P. vivax asexual stages have a strong preference for invading 
reticulocytes which cannot be maintained in in vitro culture. Therefore, 
studies with P. vivax are limited to ex vivo clinical isolates, where parasite 
load may be low and asynchronous and the parasites cannot be 
maintained for more than one or two cycles. 
In the absence of an in vitro adapted P. vivax line, the primate malaria P. 
knowlesi represents a versatile tool for studying “vivax-like” biology. P. 
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knowlesi is a parasite of the long-tailed macaque (Macaca fasicularis) (30) 
is phylogenetically closely related to P. vivax (54) and is used for in vivo 
studies in its experimental host the rhesus macaque (Macaca mulatta). 
P. knowlesi had been known to infect humans after experimental blood 
passage from a macaque to a human (80), but infections acquired 
naturally via mosquito bite were thought to be considerably rare. 
Molecular analysis of a number of malaria cases in South East Asia, has 
recently revealed that P. knowlesi is responsible for a much higher 
proportion of infections than had been anticipated (36, 160). These cases 
had been routinely misdiagnosed as P. malariae, since P. knowlesi is 
morphologically indistinguishable from P. malariae by microscopic 
examination. The 24 hour replicative cycle of P. knowlesi means the 
parasites may rapidly reach high numbers in the circulation of an infected 
individual causing severe symptoms (37). A clinical study in Malaysian 
Borneo classified one in ten P. knowlesi cases as severe, with 1-2% of 
cases leading to death (41). 
P. knowlesi is the only Plasmodium species in addition to P. falciparum, 
which has been adapted to long-term, in vitro culture (82). The genome 
sequence of P. knowlesi has recently been published (123) and 
transfection technology has been developed for P knowlesi with both 
single- and double-crossover integration possible (83, 184). Its versatility 
in both in vivo and in vitro studies and the close phylogenetic relationship 
of P. knowlesi to P. vivax identifies it as an ideal model for 
characterisation of “vivax-type” biology. 
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2. Objectives of this thesis 
This thesis describes the characterisation of a number of different aspects 
of food vacuole biology of P. knowlesi, using it as a closely related in vitro 
model of P. vivax. The versatile transfection technology of P. knowlesi is 
applied in a number of different ways to uncover differences between this 
primate malaria and the extensively studied P. falciparum. 
Using different parasite staining techniques, in combination with imaging 
of P. knowlesi expressing fluorescently tagged food vacuole proteins, the 
morphology of the food vacuole is examined. Live confocal microscopy 
and electron microscopy are used to generate images of the parasites 
undergoing haemoglobin uptake and food vacuole formation. 
The four plasmepsins in P. falciparum have been under scrutiny for a 
number of years as potential drug targets. The essentiality of the single 
plasmepsin expressed in P. knowlesi is investigated using a conditional 
protein expression system. Replacement of plasmepsinIV (pkpm4) of P. 
knowlesi with a functional copy tagged with a degradation domain, 
allowing control of protein levels in the parasite with the compound 
Shield. This system was used to study the growth rates of pkpm4-knock-
down parasites in complete medium and amino acid-limited medium.  
PfCRT is highly associated with chloroquine resistance in P. falciparum. 
The ability of this protein to modulate the chloroquine sensitivity in P. 
knowlesi is investigated by heterologous overexpression of CQS and CQR 
pfcrt alleles and the subsequent quantification of chloroquine 
susceptibility compared to wild-type P. knowlesi. 
Collectively these studies give valuable insight into how similar/dissimilar 
this organelle and the biological processes which occur within it are 
between Plasmodium species, augmenting our knowledge and assisting 
the development of effective antimalarial drugs. 
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3. Materials and Methods 
3.1. Generation of transfection vectors 
Transfection constructs were generated according to standard molecular 
biology protocols (148). Molecular cloning enzymes and restriction 
enzymes were obtained from Invitrogen, unless otherwise stated. PCR 
amplification for cloning was carried out using Phusion DNA Polymerase 
(Finnzymes) with the protocol: three minutes at 98°C, 30 cycles of the 
following denaturation, annealing and extension steps: 30 seconds at 
98°C, 30 seconds at 50-60°C (depending on primer melting temperature) 
and 90 seconds at 72°C, concluding with ten minutes of a final extension 
step at 72 °C. All primers are described in Table 1. 
 
3.1.1. Fusion protein expression vectors 
Fusion genes pkcrt-gfp, pfcrt-gfp and pkpm4-mcherry were generated in 
a double-amplification PCR fusion protocol similar to that described in 
Hobert (74). The first PCR amplification used Primer F (forward primer for 
the protein to be tagged) and the fusion primer (combines a reverse 
primer for the 5’ end of the protein to be tagged with a forward primer for 
the fluorescent tag) with the gene of interest as a template, i.e. pkcrt was 
amplified from P. knowlesi cDNA. This product was amplified by PCR and 
checked for the correct size and sufficient yield on an agarose gel. The 
product from the first reaction acts as both a template and a primer in the 
second PCR reaction, combined with a reverse primer for the fluorescent 
tag and the forward primer from the first reaction. These are used in the 
second PCR reaction with the coding sequnce for the fluorescent tag, 
generating the full gene fusion.  Product size and yield was verified on an 
agarose gel. The fusion was then cloned into the vector pCR-Blunt II-
TOPO (Invitrogen) for sequencing and subcloning into the relevant 
expression vectors.  
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PkCRT-GFP and PfCRT-GFP expression vectors were generated from the 
vector Pk_pfcrt_HB3 (Figure 3A) which was provided by Dr. David Fidock, 
Columbia University. The fusion products pkcrt-gfp and pfcrt-gfp which 
had been cloned into pCR-Blunt II-TOPO were excised using the flanking 
XhoI sites (added during PCR amplification) and inserted into 
Pk_pfcrt_HB3 which had been digested with XhoI, generating a vector 
from which either pkcrt-gfp or pfcrt-gfp are expressed from the pkcrt 
promoter with a selection cassette containing the human dihydrofolate 
reductase (h-dhfr) selectable marker. 
To generate the pkpm4-mCherry expression vector, the fusion gene 
pkpm4-mCherry (consisting of the first 91 codons of pkpm4 fused to the 
mCherry coding sequence) was amplified with 750bp of the pkpm4 
upstream UTR and cloned into pCR-BluntII-TOPO (Invitrogen). This was 
then subcloned by BglII/XhoI digestion into BglII/XhoI digested 
Pk_pfcrt_HB3 to replace the pkcrt 5’UTR and pfcrt ORF with the pkpm4 
5’UTR and pkpm4-mCherry fusion ORF. The orientation and sequence of 
the fusion genes in each of the expression vectors was confirmed by 
restriction digest analysis and sequencing. 
 
3.1.2 PfCRT expression vectors 
The expression vectors pDC_PfCRT_HB3 and Dd2trunc (Figure 3B) were 
obtained from Dr. David Fidock (56). pDC_PfCRT_Dd2full was generated 
by replacement of the truncated PfCRT Dd2 ORF in pDC_PfCRT_Dd2trunc 
with the full length PfCRT Dd2 cDNA from Pk_Pfcrt_Dd2 by XhoI digest. 
The orientation and sequence of the inserted pfcrt fragment was 
confirmed by restriction analysis and sequencing. 
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3.1.3. pkpm4 knock-out (KO) construct 
The h-dhfr_TOPO expression construct consists of h-dhfr under control of 
the constitutive P. berghei elongation-factor 1 alpha (ef1α) promoter with 
cloning sites on either side of the selection cassette for insertion of 
homologous flanking regions to allow integration of the construct at a 
specific locus by double crossover (Figure 4). Flanking regions 
homologous to the pkpm4 ORF or UTRs were amplified from P. knowlesi 
genomic DNA using primers with additional restriction sites (Table 1) and 
the products were cloned into pCR-Blunt II-TOPO. Different combinations 
of flanking regions were subcloned into h-dhfr_TOPO to generate three 
different KO constructs (Figure 4).  The KO constructs consisted of the 
following combinations of homologous flanking regions: pkpm4KO1, up1 
A B 
Figure 3. pDC_PfCRT vector and Pk_PfCRT vectors and restriction sites used for 
linearisation or cloning. A. Pk_Pfcrt replacement vector, pfcrt(red) represents 
either HB3 or Dd2 alleles. The vector can be linearised by BglII/StuI digest and 
should integrate by double cross-over into the pkcrt locus via the flanking 
regions homologous to pkcrt (green) replacing the endogenous pkcrt ORF with 
either the HB3 or Dd2 allele of pfcrt controlled by the pkcrt promoter. The h-dhfr 
under control of the constitutive P. berghei ef1α promoter allows for selection of 
transfectants with pyrimethamine. B. pDC_PfCRT expression episome. The pfcrt 
ORF (full-length HB3 or truncated Dd2 allele) is expressed under the constitutive 
P. falciparum calmodulin promoter. The expression of h-dhfr under the P. 
chabaudi dhfr/ts promoter bestows resistance to pyrimethamine. 
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and dwn1; pkpm4KO2, up2 and dwn2; pkpm4KO3, up2 and dwn3. Each 
vector was linearised before transfection with the restriction enzymes 
EcoRI and EcoRV. 
 
3.1.4 pkpm4DD replacement vector 
The Toxoplasma gondii dihydrofolate reductase-thymidine synthase (tg-
dhfr/ts) selection cassette was isolated from the plasmid b3D.DT^H.^D  
(kindly provided by Dr. Chris Janse, LUMC, Leiden, The Netherlands) by a 
HindIII digestion, overhangs were removed with Klenow Large Fragment 
DNA Polymerase (Invitrogen) and the cassette was inserted into the 
EcoRV site in pBluescript generating pBS_t-dhfr. 
A 660bp terminator region from the 3’UTR downstream of the P. yoelii 
chloroquine resistance transporter gene was isolated from Pk_Pfcrt by 
XhoI/SpeI digest, blunt-ended and inserted into the blunt-ended EcoRI 
site in pBS_t-dhfr followed by the upstream insertion of  SalI/NotI C-
terminal destabilisation domain (DD) fragment excised from pTunerC 
(Clontech). The pkpm4 ORF was amplified with primers pkpm4F and 
pkpm4R (Table 1), digested with BamHI and inserted into the BamHI site 
immediately upstream of the DD tag, generating a flanking region 
homologous to codons 256 to 451 of pkpm4, missing the stop codon and 
in frame with the DD tag. A region of the pkpm4 3’UTR 1353-2156 
nucleotides downstream of the pkpm4 start codon, was amplified with 
primers 3’pkpm4 flank F and 3’pkpm4 flank R (Table 1) and cloned into 
the EcoRV site downstream of the tg-dhfr selection cassette. Each point in 
the cloning procedure was verified by restriction digest analysis before 
proceeding to the next cloning step. 
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3.2. P. knowlesi erythrocytic stages in vitro culture. 
3.2.1 Routine in vitro culture of P. knowlesi 
Parasites were cultured according to Kocken et al. (82). In brief, cultures 
were routinely kept at 5% haematocrit in rhesus macaque erythrocytes 
and complete medium (RPMI-1640, 20% heat-inactivated human serum, 
15µg/ml gentamycin) in air tight culture flasks which were gassed with 
5% CO2, 5% O2, 90% N2 gas-mix and incubated at 37°C with gentle 
shaking. 
The cultures were maintained at a parasitaemia of 0.1-2%, unless higher 
numbers were required for specific procedures when the parasitaemia was 
allowed to increase up to 12% with haematocrit reduced to 2%. Higher 
parasitaemias necessitated more frequent refreshing of the medium. 
Cultures were routinely checked by Giemsa stain and the parasitaemia 
counted. To refresh the medium, the cells were spun at 750xg for 5 
minutes at room temperature, the supernatant removed and fresh 
medium added with fresh rhesus erythrocytes if required, keeping the 
up2 
up1 
dwn1 
dwn3 
dwn
2 
Figure 4. Integration vectors generated for pkpm4 knock-out. A number of 
different regions of the pkpm4 locus (top) were amplified by PCR and cloned in 
different combinations to flank the h-dhfr expression cassettte in hdhfr_TOPO 
(bottom), generating three different knock-out constructs. Each flanking region 
corresponds to the following sequence of the locus with respect to the start 
codon: up1, -648 to 32; up2, 1 to 842; dwn1, 2017 to 2796; dwn 2, 468 to 
1330; dwn3, 933 to 1850. 
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period of time the parasites are at room temperature as short as possible. 
The culture was then gassed and replaced in the shaking incubator at 
37°C. 
3.2.2 Synchronisation – alanine treatment 
To achieve a parasite culture in which all the parasites are at a similar 
stage in the cycle, it is necessary to carry out a synchronisation 
procedure. An alanine treatment results in a culture containing only 
young rings, the more mature stages have a more permeable host cell 
membrane and so are more susceptible to osmotic lysis. Five volumes of 
alanine solution (0.3M l-alanine, 1mM HEPES, pH 7.5) was added to one 
volume of cell pellet and incubated in a 37°C water bath for 20-30 
minutes. The cells were washed twice with 20 volumes of RPMI-1640 and 
returned to culture. 
 
3.2.3 Isolation of trophozoites and schizonts – Magnetic Cell 
Sorting (MACS) 
The by-product of haemoglobin degradation, haemozoin is weakly 
magnetic due to its iron component. Mature asexual stages of the 
Plasmodium parasite accumulate this pigment as they digest more 
haemoglobin. The paramagnetic nature of these mature stages means 
that they can be purified from uninfected erythrocytes and younger ring 
stages which have not yet formed haemozoin (125). 
A cell pellet of P. knowlesi trophozoites of approximately 500µl and at 
least 2% parasitaemia was washed once with RPMI-1640 and  
resuspended in MACS Buffer (2% bovine serum albumin in PBS, 2mM 
EDTA, pH7.5, filter sterilised). 
A MACS CS-column (Miltenyl Biotech) was fitted to the Vario-MACS 
magnet (Miltenyl Biotech), and equilibrated with MACS Buffer for 10 
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minutes. The parasite suspension was then added to the top of the 
column in the magent and allowed to slowly filter through the column, 
until the parasite suspension had reached the bottom of the column. The 
tap was closed and the cell-filled column was incubated for 15 minutes at 
room temperature. The column was then washed with at least 30ml of 
MACS buffer, allowing the eluate to slowly drip out of the tap, until the 
eluate was free of cells. The column was removed from the magnet and 
flushed with 20ml of MACS buffer to collect the purified cells which were 
washed in RPMI-1640 and quantified in a haemocytometer and 
parasitaemia determined on Giemsa stained smears. 
 
3.2.4 Percoll purification of schizonts 
More mature asexual stages are less dense than the uninfected 
erythrocytes and can therefore be separated on a density gradient such 
as Percoll. 2.5ml of P. knowlesi-infected erythrocytes at 5-10% 
parasitaemia was washed twice in RPMI-1640 and resuspended to 
approximately 30% haematocrit, then gently applied to the top of a 7ml 
cushion of 52% Percoll in RPMI-1640 in a 15ml centrifuge tube, taking 
care not to disturb the interface between the Percoll and the cell 
suspension. 
The gradient was spun at 1000xg for 20 minutes at room temperature 
with a low brake. The ring and trophozoite stages, along with the 
uninfected erythrocytes go through the Percoll and form a pellet, while 
the less dense schizonts remain at the top of the Percoll cushion. These 
were removed and washed at least three times in RPMI-1640 to remove 
the Percoll. 
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3.2.5 Cloning P. knowlesi pkpm4DD by limiting dilution 
The number of parasites per millilitre was calculated by counting the 
cells/ml in a haemocytometer and the parasitaemia on Giemsa stained 
smears. The parasites were diluted to 100 parasites/ml in 5% 
haematocrit, and subsequently diluted to 2 parasites/ml in complete 
medium with 5nM pyrimethamine and 1µM Shield (Clontech). Four 96-
well plates were filled with 100µl of the parasite suspension containing 2 
parasites/ml, resulting in approximately 20% of the wells containing a 
single parasite. Ten wells were filled with 100µl of the 100 parasites/ml 
suspension for monitoring parasite growth. The plates were placed in a 
sterilised, air-tight container, which was gassed with 5% O2, 5% CO2, 
90% N2 gas mix, sealed and incubated at 37°C. The selection medium 
(complete medium, 5nM pyrimethamine, 1µM Shield) in the plates was 
replaced twice a week. After two weeks, smears of each well were made 
and Giemsa stained for screening. Any positive wells were screened for 
pkpm4DD integration by PCR on 2µl of cell pellet using primers 5’ pkpm4 
F and dd R (Table 1) and Phusion Blood II DNA Polymerase (Finnzymes) 
in the following cycling protocol: initial five minutes at 98C, 35 cycles of 
98C for one second, 60C for five seconds and 72C for 30 seconds followed 
by a final extension step of 72C for one minute. PCR reactions were 
checked on an agarose gel and any isolates for which the PCR was 
positive were retained in culture for further genotypic analysis. 
 
3.3. P. knowlesi transfection 
3.3.1 Amaxa Nucleofector transfection 
At least 5×107 schizonts directly from culture (synchronised by alanine 
treatment) or purified by either MACS or Percoll gradient, were 
resuspended in 100µl of Amaxa nucleofector solution (Lonza AG) in an 
Amaxa electroporation cuvette (Lonza AG). 5-10µg of plasmid DNA was 
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added and the electroporation was carried out in an Amaxa Nucleofector 
device (Lonza AG) using programme U-033. The electroporated mixture 
was immediately added to 10ml of complete medium with rhesus RBCs at 
5% haematocrit, gassed and incubated at 37°C. 24 hours post-
transfection, the medium was refreshed with complete medium containing 
5nM pyrimethamine. The medium was subsequently refreshed every 
second day with regular screening of Giemsa stained smears to check for 
emerging transfectants. Pyrimethamine resistant parasites emerged 2-14 
days post-transfection. 
 
3.3.2 BioRad transfection 
P. knowlesi were transfected in a protocol similar to that described in van 
der Wel et al. (180) with minor modifications. Briefly, 5×108 mature 
schizonts (≥6 nuclei) from synchronous in vitro culture were washed 
twice in RPMI-1640 and once in cytomix (120mM KCl, , 5mM MgCl2, 
0.15mM CaCl2, 10mM KH2PO4, pH 7.6, 25mM HEPES, pH 7.6, 2mM EGTA, 
pH 7.6) then resuspended in 700µl of cytomix in a 4mm electroporation 
cuvette on ice. 50µg of linearised plasmid DNA was added, and the 
electroporation was carried out in a BioRad GenePulser II with 
Capacitance Extender at 2.5kV, 25µF, 200Ω (time constant 0.90). 
Following electroporation, the cell suspension was resuspended in 20ml of 
complete medium at 5% haematocrit, gassed and incubated at 37°C. 24 
hours post-transfection, the parasites were washed once in RPMI-1640 
and the medium was refreshed with complete medium containing 5nM 
pyrimethamine. The culture was refreshed every two days and regularly 
screened by Giemsa stained smears for emerging transfectants. 
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3.4. Genotypic analysis 
3.4.1. P knowlesi genomic DNA isolation 
Genomic DNA was isolated from P. knowlesi infected RBCs, using the 
MasterPure DNA Purification Kit for Blood Version II (Epicentre 
Biotechnologies). A red blood cell lysis step in Red Blood Cell Lysis Buffer, 
was followed by centrifugation to pellet the parasite cells, which were 
then lysed with Cell Lysis Buffer. The proteins were precipitated with 
Protein Precipitation Buffer, and pelleted by a centrifugation step. The 
genomic DNA was precipitated from the supernatant with cold 
isopropanol, and centrifuged at 13000xg at 4°C for 20 minutes. The DNA 
pellet was washed in 70% ethanol, dried and resuspended in TE Buffer 
and stored at 4°C. 
 
3.4.2 Integration PCR 
Integration of the pkpm4DD_tgdhfr construct was detected by PCR on 
genomic DNA isolated from the transfectant parasites using combinations 
of primers specific to sequences within the integration construct and 
sequences outside the regions of the locus used for homologous 
integration. To detect the presence of the intact wild-type locus, primers 
5’ pkpm4 F (P1) and 3’pkpm4 R (P2) were used. These sequences are 
present in both the wild-type and transfectant parasites, but the product 
of this reaction in the wild-type is 1.5kb, while the product in the 
transfectant parasites would expected to be approximately 7kb and too 
large to readily amplify by a standard PCR reaction, so should be absent 
in a PCR on genomic DNA from transfectant parasites. Integration of the 
construct was confirmed by PCR with primers 5’ pkpm4 F (P1) and DD R 
(P3) to detect integration at the 5’ end of the construct and primers tg-
dhfr F (P4) and 3’pkpm4 R (P2) to detect integration at the 3’ end of the 
integration construct (Table 1). The PCR reactions using recombinant Taq 
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Polymerase (Invitrogen) were as follows: three minutes at 94°C, then 35 
cycles of the following denaturation, annealing and extension steps: 30 
seconds at 94°C, 30 seconds at 56°C and 90 seconds and 72°C, 
concluding with ten minutes of a final extension step at 72 °C. 
 
3.4.3 Southern Blotting 
5µg of P. knowlesi genomic DNA was digested with HpaI (New England 
Biolabs) and separated on a 0.7% agarose gel. The agarose gel 
containing the separated DNA was exposed to UV light for 5 mins, 
denatured in 1.5M NaCl, 0.5M NaOH for 15 minutes at room temperature, 
neutralised in 1.5M NaCl, 0.5M Tris-HCl (pH7.5) for 15 minutes at room 
temperature and washed in 2× sodium chloride-sodium citrate (SSC). The 
DNA was transferred to a positively charged nylon membrane (Nytran 
SuPerCharge, Whatman) by capillary transfer in 2xSSC buffer overnight.  
The DNA was cross-linked to the membrane using programme C3 in a 
BioRad GS Gene Linker (150mJoules), the membrane was allowed to dry 
at room temperature and was stored at 4°C until hybridisation of probes. 
The templates for probes were prepared by PCR using Phusion DNA 
Polymerase on the pkpm4DD integration plasmid using specific primers  
pkpm4 probe F, pkpm4 probe R, tg-dhfr probe F, tg-dhfr probe R (Table 
1). The PCR products were purified and used as templates to generate 
DIG-labelled probes in an overnight reaction at 37°C using the DIG High 
Prime DNA Labelling and Detection Starter Kit II (Roche). Membranes 
were prehybridised in DIG EasyHyb (Roche) and the heat-denatured 
probe was added to a concentration of approximately 50ng/ml  in DIG 
EasyHyb and hybridised overnight at 42°C. Low stringency (2% SSC, 
0.1% SDS, 2x5 minutes at room temperature) and high stringency (0.5% 
SSC, 0.1% SDS, 2x15 minutes at 65°C) washes were carried out before 
blocking the membrane with Blocking buffer (DIG Wash and Block Buffer 
Kit, Roche), followed by addition of alkaline phosphatase(AP)-linked 
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antibody solution (1:10,000 in Blocking buffer) recognising the DIG label 
(Roche). After washing, the chemiluminescent substrate, CSPD (Roche) 
was added and the membrane was exposed to the chemiluminescent 
detector BioRad ChemiDoc XRS for 60 minutes and imaged using Quantity 
One 4.5.0 software. 
 
3.4.4 Plasmid rescue 
100ng of genomic DNA was transformed into competent Escherichia coli 
and plated on selective agar. Colonies which arose after overnight 
incubation at 37°C were cultured for mini-prep plasmid purification (148) 
and the purified plasmids were analysed by restriction digests. 
 
3.4.5 Reverse transcriptase (RT)-PCR 
mRNA was isolated from parasites using the Nucleospin RNA Blood 
isolation kit, according to the manufacturer’s instructions. cDNA was 
generated from the parasite mRNA using random hexamers as primers 
and the reverse transcriptase in Superscript III First-Strand Synthesis 
Supermix (Invitrogen), according to the manufacturer’s instructions. 
Specific pfcrt sequences were then amplified from the cDNA using 
recombinant Taq Polymerase (Invitrogen) and primer sets pfcrt rt-pcr F1 
and R1 and pfcrt rt-pcr F2 and R2 (Table 1) which are specific for pfcrt 
but not pkcrt. PCR products were analysed by agarose gel 
electrophoresis. 
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3.5. Parasite imaging 
3.5.1. Light microscopy 
P. knowlesi (Hcc) and P. falciparum (NF54) were both in vitro cultured. P. 
cynomolgi (M strain) parasites were obtained from an infected rhesus 
macaque (Macaca mulatta) as part of an unrelated drug study. Images of 
P. vivax Chesson strain asexual stages came from an archived Giemsa-
stained blood smear of P. vivax-infected Aotus azarae boliviensis 
erythrocytes (81). The Giemsa-stained smears were viewed with an 
Olympus BX41 light microscope and imaged with Olympus CellB imaging 
software. 
 
3.5.2. Confocal microscopy 
In vitro cultured P. knowlesi parasites were washed in Ringers Solution 
(122.5 mM NaCl; 5.4 mM KCl, 1.2 mM CaCl2, 0.8 mM MgCl2, 11mM D-
glucose, 25 mM HEPES, 1 mM NaH2PO4, pH 7.4), then allowed to settle on 
a poly-l-lysine coated glass slide in a perfusion chamber. The parasites 
were incubated with 5µM LysoSensor Blue (Molecular Probes) or 1µM 
Hoechst (Molecular Probes) in Ringers solution, before a number of 
perfusions with Ringers Solution in the chamber to wash away excess 
stain. 
The stained parasites were imaged using a Zeiss Axiovert 100M 
microscope with a 63x water-corrected lens and a Zeiss LSM510 confocal 
system (Zeiss, Germany) equipped with visible and UV laser lines. LS Blue 
was excited at 364 nm with the UV laser line and emission detected using 
a 385–470 nm bandpass filter. pHluorin and GFP were excited using the 
488 nm Argon laser and the emission detected using an LP 505nm filter. 
mCherry was excited at 543nm with the Helium-Neon laser and the 
emission was detected using an LP 560nm filter. Images were analysed 
using ImageJ version 1.43 (NIH). 
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3.5.3. Electron microscopy  
P. knowlesi parasites were isolated by MACS purification and fixed for 
electron microscopy according to the Tokuyasu technique. The cells were 
incubated in the first fixation buffer I (0.2M PHEM buffer, 8% 
paraformaldehyde, 0.2% glutaraldehyde) at room temperature for five 
minutes, followed by one hour incubation in fixation buffer II (0.1M PHEM 
(60mM PIPES, 25mM HEPES, 10mM EGTA, 2mM MgCl2, pH 6.9),  4% 
paraformaldehyde, 0.1% glutaraldehyde) at room temperature. The cells 
were stored in 0.1M PHEM buffer with 4% paraformaldehyde at 4°C until 
proceeding to embedding. The fixed cells were washed in 50mM glycine in 
PBS before resuspension in 1% gelatin, followed by embedding in 10% 
gelatin. The gelatin was sliced into approximately 2mm cubes which were 
infused overnight at 4°C with 2.3M sucrose in PBS. Gelatin blocks infused 
with sucrose were mounted on cryo pins and frozen in liquid nitrogen. 
Ultrathin (90-120nm) sections were cut at -120°C with a Leica EM FC6 
cryo-microtome and individual sections were placed on formvar-coated 
copper EM grids (Plano) in 1.15M sucrose, 1% methylcellulose/PBS. The 
grids were incubated in 2% gelatin/PBS at 37°C for 15 minutes, followed 
by incubation in PBS at 37°C for 15 minutes, washed in PBS, then 
extensively washed in distilled water on ice. The grids were dipped in 
1.7% methylcellulose, 0.45% uranyl acetate solution and dried at room 
temperature. The grids were viewed with a Leica EM900 scanning electron 
microscope. 
 
3.6. In vitro drug assays 
The antimalarial activity of chloroquine was measured against P. knowlesi 
transfectants using the Plasmodium lactate dehydrogenase (pLDH) assay. 
This enzyme is produced by live parasites and is detectable in trophozoite 
and schizont stages. pLDH catalyzes the conversion of 3-acetylpyridine 
adenine dinucleotide (APAD) and lactate (both present in the substrate 
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buffer) to APADH and pyruvate. The enzyme diaphorase subsequently 
converts Nitro Blue Tetrazolium (NBT) (both also present in the substrate 
buffer) to Nitro Blue Formazan (NBF) using APADH as a reducing agent. 
NBF is a purple soluble substance that can be measured at wavelength 
655nm. P. knowlesi cultures of 0.5% young rings which had been 
synchronised by alanine treatment in the previous cycle, were added to a 
two-fold dilution series of the drug (50mg/ml chloroquine phosphate, 
Bayer) from 0.057ng/ml to 116.25ng/ml  in complete medium. The 
parasite cultures were incubated in flat-bottomed, 96-well plates at 37°C 
in the drug for approximately 40 hours (one and a half cycles), until the 
parasites had matured to the trophozoite or schizont stage, when the cell 
pellets were washed once in PBS and frozen at -20°C overnight. The LDH 
assay was carried out on the thawed cell pellets. 0.5mg/ml of NBT, 1U/ml 
diaphorase and 50µg/ml APAD were added to LDH buffer (100mM Tris-
HCl, pH 8.0, 50mM sodium l-lactate, 2.5% Triton X-100) which was then 
added to the thawed cell pellet and incubated for 30 minutes, protected 
from light at room temperature with shaking. The optical density (OD) at 
655nm of each well was measured in a BioRad 680 microplate reader. The 
OD values were used to calculate the %growth using the formula: 
 
 
Parasite inhibition values were plotted and statistical analyses performed 
using Graphpad Prism v5.0b. 
 
3.7. Parasite growth rate assays. 
Duplicate cultures of each clone were prepared in complete medium 
(RPMI-1640, 20% heat-inactivated rhesus serum (pooled from fasting 
animals), 15µg/ml gentamycin) one supplemented with 1µM Shield and 
one with no Shield added. 
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Custom produced RPMI-1AA (AthaenaES, Baltimore, USA) is similar to 
standard RPMI-1640 culture medium, but is deficient for all amino acids 
except isoleucine, which is present at the same concentration as in 
standard RPMI-1640 (50mg/l). Duplicate cultures were prepared in amino 
acid limited medium (RPMI-1AA, 20% rhesus serum, 15ug/ml 
gentamycin) also in the same shield concentrations. 
The culture medium was changed every 24 hours (±1 hour), at the same 
time a thin smear was taken of each culture. The cultures were 
propagated simultaneously until the parasitaemia reached a limiting point 
(>3%). At the end of the assay, the smears of each culture from each 
time point were Giemsa-stained, blinded and the parasitaemia was 
calculated by counting a minimum of 5000 red blood cells. Growth curves 
were plotted and linear regression and statistical analysis were carried out 
using Graphpad Prism v5.0b. 
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Table 1. Primers used in the course of this research. Underlined 
sequences indicate restriction sites used for cloning.  
Primer name Sequence 
Cloning  
Pkpm4-mCherry F GTACATTCGAGCATTTTTAGAGTTATG 
Pkpm4-mCherry fusion CCTCCTCGCCCTTGCTCACCATCTTGTCATAGGGTCTCTCTA 
Pkpm4-mCherry R (XbaI) TCTAGATTACTTGTACAGCTCGTCCATGC 
Pfcrt-gfp F (XhoI) CTCGAGATGAAATTCGCAAGTAAAAAAAATAATCAAAAAAATTCAAGC 
Pfcrt-gfp fusion GAATAATTCTTCACCTTTAGACATTTGTGTAATAATTGAATCGACGTTGG 
Pkcrt-gfp F (XhoI) CTCGAGATGAAGATCTTGAAAAAGAAGAAAAAGGGGAAC 
Pkcrt-gfp fusion GAATAATTCTTCACCTTTAGACATTTGTGTTATTATCGATTCG 
gfp R (BamHI) CGGGATCCTTATTTGTATAGTTCATCC 
pkpm4F ATGGATATAGCAGTGAAAGAAC 
pkpm4R (BamHI) CGGGATCCCGTTCTTAGCGATAGC 
3’pkpm4 flank F TCGGAATGGTTAGGAGAAGAATC 
3’pkpm4 flank R CACTTATCGTTTGTTATTTTCTATC 
Pkpm4KO up1 F (EcoRI) GAATTCATCTGTTCGGCATTCGTGC 
Pkpm4KO up1 R (PstI) CTGCAGTGAGTAGTCTTGTTCTTTCACTGC 
Pkpm4KO up2 F (EcoRI) GAATTCATGGATATAGCAGTGAAAGAAC 
Pkpm4KO up2 R (PstI) CTGCAGGAAGGTAGAAGGTGAATAAGG 
Pkpm4KO dwn1 F (XhoI) CTCGAGGGTCTCTCCTTACTTTTAGCAC 
Pkpm4KO dwn1 R (XhoI) CTCGAGGATATCTTATTTCCTCAGTGTCCCCTTCG 
Pkpm4KO dwn2 F (XhoI) CTCGAGGACACTGGTTCAGCCAACTTGTGGGTCCCAAGTAAG 
Pkpm4KO dwn2 R (XhoI) CTCGAGGATATCCCGACACTCTCGTTGTCGTAGTCAAAAACG 
Pkpm4KO dwn3 F (XhoI) CTCGAGCACGACTTGTACTGGCAAATTGATTTAGATG 
Pkpm4KO dwn3 R (XhoI) CTCGAGGATATCGCCCGCTGAATCATGGTCGTTC 
Checking  pkpm4DD integration 
5’ pkpm4 F (P1) GTAACACTCATCCAGAAATACC 
3’ pkpm4 R (P2) GTGGTAATAAGAAGATTTATCC 
tg-dhfr F (P3) TCCAGATGGAGATGGCTGTC 
dd R (P4) GAGATGGTTTCCACCTGCACTC 
Amplification of templates for Southern blot probes 
Pkpm4 probe F GGAAGGACAATGGATGACCGAACGG 
Pkpm4 probe r GCGTTCCTTGTTGAGGATGTTCACAATGG 
Tg-dhfr probe F GCATGGACAAATGACCCAAGGTTACT 
Tg-dhfr probe r CTTGTTTGCCTTGCAAGTGATATACATC 
RT-PCR 
Pfcrt rt-pcr F1 TTCAAGCAAAAATGACGAGC 
Pfcrt rt-pcr R1 GAGCACATTTACCAAGACAAG 
Pfcrt rt-pcr F2 CGGTGATGTTGTAAGAGAACCAAG 
Pfcrt rt-pcr R2 CGGAATCTTCATTTTCTTCATTTCTC 
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4. Results 
4.1. Food vacuole morphology of P. knowlesi 
In order to visualise and characterise the morphology of the P. knowlesi 
food vacuole, some specific features of the organelle were investigated. 
The presence of haemozoin is used as an indicator for haemoglobin 
catabolism. Low pH is another distinct attribute of the Plasmodium food 
vacuole, which can be used as a marker for the organelle. These 
characteristics were used in preliminary experiments to compare the food 
vacuoles of P. knowlesi to those of the well-characterised P. falciparum. 
4.1.1. Haemozoin in Giemsa stained smears 
Using the haemozoin pigment as a marker representing the food vacuole, 
the Giemsa stained slides were analysed for parasites throughout the 
asexual cycle (Figure 1). 
In P. falciparum, the first visible signs of haemozoin are confined to a 
single location within the trophozoite (Fig. 3B), which continues to 
accumulate pigment due to ongoing haemoglobin degradation as the 
parasite matures (Fig. 3C, D). However, both P. cynomolgi and P. vivax 
trophozoites display diffuse scattering of small pigment crystals 
throughout the parasite cytoplasm (Fig.3J, N). As the parasites mature, 
these haemozoin crystals appear to coalesce into larger lumps (Fig. 3K, 
O) which eventually form a single mass of pigment in very mature 
schizonts (Fig. 3L, P). Scattered pigment crystals can also be seen in P. 
knowlesi trophozoites and early schizont stages (Fig. 3F, G), which 
similarly form a single large compartment containing haemozoin by the 
late schizont stage (Fig. 3H). In the trophozoite and early schizont stages, 
the pigment containing vacuoles often appear to be in close proximity to 
the plasma membrane. 
Using visible haemozoin in Giemsa stained parasites as a preliminary 
marker for food vacuoles, this would suggest that P. falciparum is the 
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only parasite in this group which produces its haemozoin in a single 
compartment, the remaining species forming crystals of pigment 
throughout the parasite cell. Using this method to identify food vacuoles, 
the cells are fixed to a glass slide, making it impossible to determine if 
these pigment-containing compartments are discrete vacuoles, or if they 
are interconnected as part of a vacuolar network in the cell. 
 
 
 
 
 
 
 
 
 
 
4.1.2. LysoSensor Blue staining 
In order to visualise the food vacuoles of live in vitro cultured P. knowlesi 
asexual stage parasites, the acidotropic stain, LysoSensor Blue was 
utilised. This dye accumulates and fluoresces in acidic organelles and has 
previously been used for food vacuole imaging in P. falciparum (192). 
Live P. knowlesi  parasites were stained with LysoSensor Blue and imaged 
using a confocal microscope (Fig. 4). A number of discrete compartments 
within the parasites could be seen which peaked in number in early 
schizonts (Fig. 4G) and appeared to coalesce as the parasite matured into 
a single large acidic vacuole, which contained a dense lump of haemozoin 
Figure 3. Giemsa stained 
smears of the asexual stages of 
human and primate Plasmodium 
species. Haemozoin is visible as 
brown lumps in the parasite. P. 
falciparum contains only a single 
mass of haemozoin. In the other 
species, haemozoin can be seen 
in lumps scattered throughout 
the parasite cell. Pf, P. 
falciparum; Pk, P. knowlesi; Pv, 
P. vivax; Pc, P. cynomolgi; R, 
ring; T, trophozoite; ES, early 
schizont; LS, late schizont. Scale 
bar 1µm. 
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(Fig. 4L). This is in contrast to LysoSensor Blue staining in P. falciparum 
trophozoites where a single acidic vacuole is visible (Fig. 4M). It was also 
noted that not all of the acidic vacuoles contain haemozoin, while not all 
the vacuoles containing haemozoin appear to be acidic (Fig. 4F, I). 
LysoSensor Blue staining was also carried out on live ex vivo P. cynomolgi 
parasites and viewed with a fluorescent microscope displaying numerous 
(>100), very small acidic vacuoles, consistent with the pattern of 
haemozoin in the parasites. Confocal imaging of stained P. cynomolgi was 
not possible and imaging with a normal fluorescent microscope was very 
difficult with the number and size of the vesicles. 
 
 
 
 
 
 
 
 
 
 
 
Precise co-localisation of the LysoSensor Blue staining and haemozoin in 
P. knowlesi was made difficult due to the sensitivity of the food vacuole to 
light; the pH gradient is rapidly lost under illumination (192). Therefore 
an alternative approach was taken, using fluorescently tagged food 
vacuole proteins, as a more stable marker for food vacuoles. 
Figure 4. Live confocal imaging of 
LysoSensor Blue stained Plasmodium asexual 
stages. Pk. P. knowlesi asexual cycle. 
Trophozoites contain numerous acidic 
compartments which combine as the parasite 
matures to form a single acidic bacuole in 
late schizonts. Some acidic vacuoles do not 
appear to contain pigment (yellow arrow, 
panel F). Conversely, some pigment-
containing vacuoles do not stain with 
LysoSensor Blue (white arrow, panel I). Pf. 
P. falciparum trophozoites contain a single 
acidic vacuole, in which a mass of haemozoin 
can be seen. R, ring; T, trophozoite; ES, 
early schizont; LS, late schizont. Scale bar 
1µm. 
 
Merge 
R 
T 
ES 
LS 
LS Blue DIC Pk 
Pf 
A B 
E 
I 
J 
F 
C 
D 
G 
K L 
H 
M N O 
 58 
 
4.1.3. Fluorescent tagging of food vacuole proteins 
C-terminal fusions of the food vacuole proteins PkCRT (chloroquine 
resistance transporter) and PkPM4 (plasmepsinIV) to GFP and mCherry, 
respectively, were generated. The fusion proteins were cloned into 
expression vectors (Figure 3) under the control of the homologous 
promoter to allow correct stage expression and to avoid aberrant 
localisation due to overexpression and incorrect timing of expression. 
The expression episomes were transfected into P. knowlesi using the 
Amaxa nucleofector system. Transfectant cultures were kept under 
pyrimethamine selection and resistant parasites emerged within 10 days, 
these live parasites were imaged with a confocal microscope. Loss of pH 
gradient due to illumination did not affect imaging of the fluorescent food 
vacuole proteins, allowing morphological studies in live parasites. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Expression episomes for fluorescently-tagged food vacuole proteins. 
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4.1.3.1. PkCRT-GFP 
PkCRT is an integral membrane protein in which both the N- and C-
termini are predicted to be exposed on the cytoplasmic face of the food 
vacuole membrane. The PkCRT-GFP fusion protein should indicate the 
location of food vacuole membranes within the parasite. The fluorescent 
signal in parasites expressing PkCRT-GFP (Fig. 6) appeared weak in the 
late ring stage in small points, which increased in number and signal 
strength as the parasites matured. The signal was most strong in mature 
schizonts when the food vacuoles have combined together to form a small 
number of larger vacuoles. It was only at the point where the parasite 
had formed one or two large vacuoles that the membrane location of the 
fluorescent tag was clearly distinguishable, the vacuoles in earlier stages 
were too small and too numerous to allow clear resolution of the 
membrane structure.  
 
 
 
 
 
 
 
 
4.1.3.2. PkPM4-mCherry 
PkPM4 is trafficked to the parasite plasma membrane then is ingested 
with the haemoglobin on the membrane of the endocytic vesicles (12). 
Once the vesicle is acidified, the protein is cleaved from its 
transmembrane domain and released into the lumen of the vesicle. Thus, 
Figure 6. PkCRT-GFP episomal 
expression in P. knowlesi asexual 
stages. the fluroescent protein can 
be seen associated with 
haemozoin-containing vacuoles in 
trophozoites and schizonts. Scale 
bar 1µm. 
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PkPM4 with a C-terminal mCherry tag allows luminal staining of P. 
knowlesi food vacuoles. The signal from PkPM4-mCherry was clearly 
visible in transfectant parasites from an early stage in the asexual cycle 
(Fig. 7) and provided clear resolution of individual vacuoles.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PkPM4-mCherry positive vacuoles appear numerous in trophozoite and 
early schizont stages, often located at the periphery of the parasite cell 
adjacent to the plasma membrane in trophozoites. As the parasites 
mature, the vacuoles grow larger in size and smaller in number, 
Figure 7. PkPM4-mCherry episomal expression in P. knowlesi asexual stages. 
Expressed from an early stage from the pkpm4 promoter, this protein is clearly 
present in multiple vacuoles which also contain haemozoin. Vacuoles were 
observed in trophozoites and early schizonts with PkPM4-mCherry, but no visible 
haemozoin (grey arrows, panels E and I). Faint fluorescence is also visible in the 
daughter merozoites in the late schizont. R, ring; T, trophozoite; ES, early 
schizont; LS, late schizont. Scale bar 1µm. 
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ultimately becoming a single vacuole as the parasite forms the daughter 
merozoites (Fig. 7M). A number of vacuoles were observed which 
contained the fluorescent PM4 protein, but did not have any visible 
haemozoin (arrow, Fig. 7F). A faint, dispersed signal of PkPM4-mCherry 
was also observed in the daughter merozoites in a number of segmented 
schizonts (Fig. 7M). 
4.1.3.3. PfPM4-pHluorin 
The expression vector pARL_pkpm4pHluorin was provided by Prof. M. 
Lanzer, which expresses pHluorin , a pH sensitive mutant of GFP fused to 
the N-terminus of PfPM4, which targets the fusion to the food vacuole 
(89). It was evaluated if P. knowlesi parasites expressing this fusion 
protein could be utilised to compare the pH of the individual food vacuoles 
and allow discrimination of separate vesicles from tubular networks. P. 
knowlesi parasites were transfected with the expression vector and 
successfully expressed the fusion protein which displayed a similar 
localisation pattern to the PkPM4-mCherry fusion protein (Fig. 7). 
Unfortunately, the vacuoles are too small and move too rapidly for 
accurate quantification of fluorescence intensity and pH comparisons 
could not be made. 
 
 
 
 
 
 
 
Figure 8. PfPM4-pHluorin 
episomal expression in P. 
falciparum (A-C) and P. knowlesi 
(D-F) erythrocytic stages. The 
flurorescent protein is visible in a 
number of different locations 
within the P. knowlesi parasite, 
while is confined to a single 
location in P. falciparum. Scale 
bar 1µm. 
P. falciparum  
P. knowlesi  
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4.1.4. Co-localisation of acidic vacuoles and fluorescently tagged 
food vacuole proteins. 
The nature of the individual vacuoles in P. knowlesi was further probed by 
LysoSensor Blue staining of pkcrt-gfp and pkpm4-mCherry transfectants 
(Fig. 9). LysoSenor Blue similarly stains multiple compartments of the 
transfectant P. knowlesi parasites, most of which are co-localised with the 
fluorescent food vacuole proteins. There is a small number of vacuoles 
however which are acidic, evident from the LysoSensor Blue staining, but 
do not appear to contain any of the fluorescent food vacuole marker 
protein, as seen most distinctly in the stained PkPM4-mCherry parasites 
(Figure 9G). These 2D studies obtain only the signal from the vacuoles 
within a slice of the parasite approximately 0.5-1µm thick, so it cannot be 
certain that the vacuole of interest has moved out of the focal plane 
between scans from the different lasers. It is possible that slight 
differences in the alignment of the microscope lasers fail to accurately 
quantify the fluorescent intensity in precisely the same position within the 
cell.  
 
 
 
 
 
 
 
 
 
 
Figure 9. Live confocal imaging of LysoSensor blue stained transgenic P. 
knowlesi parasites expressing fluorescently tagged food vacuole proteins. Acidic 
vacuoles could be observed which did not appear to contain either haemozoin 
or a food vacuole marker protein (yellow arrow, panel G). Scale bar 1µm. 
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Figure 10. Series of z-stack images of 
LysoSensor Blue stained P. knowlesi 
expressing PkPM4-mCherry. Moving left to 
right represents slices of the cell from 
bottom to top. In slices 2-4 a number of 
vacuoles can be seen stained with 
LysoSensor Blue, but PkPM4-mCherry is 
absent. 
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To attempt more extensive mapping of fluorescent markers within the 
entire cell and possibly more accurate co-localisation of LysoSensor Blue 
and fluorescent food vacuole proteins, z-stacks through whole parasites 
were compiled. It was necessary to optimise settings for rapid scanning to 
capture signals for both channels from one slice as quickly as possible 
before vacuoles have moved too much, while maintaining adequate 
resolution. 
Successive scans at intervals of 450nm from bottom to top through an 
entire P. knowlesi-infected red blood cell generated a series of images at 
different planes within the cell (Fig. 10). Each slice corresponds with the 
same plane of the cell for both mCherry and LysoSensor Blue.  A number 
of different vacuoles are stained with LysoSensor Blue, most of which also 
contain PkPM4-mCherry. However it is evident from slices 2-4 that there 
one or two vacuoles which are stained with LysoSensor Blue but do not 
contain PkPM4-mCherry.  
4.1.5. Electron microscopy of P. knowlesi  
In order to visualise the smaller vacuoles of the haemoglobin uptake 
system in P. knowlesi, electron microscopy was carried out on MACS 
purified P. knowlesi trophozoites (Fig. 11). It is clear from EM images of 
P. knowlesi trophozoites, that haemoglobin is ingested by the parasite at 
multiple points along the parasite plasma membrane, where haemoglobin 
degradation takes place almost immediately, forming haemozoin. This is 
evident from the crystals visible in all the small vacuoles which are 
located along the inside of the parasite plasma membrane, complimenting 
the localisation of the vacuoles in LysoSensor Blue stained wild-type P. 
knowlesi and P. knowlesi expressing PkPM4-mCherry. 
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P. knowlesi appears to contain multiple food vacuoles, in contrast to P. 
falciparum which forms a single acidic vacuole. The numerous acidic 
vacuoles were also observed to contain food vacuole marker proteins, 
with the exception of a number of vesicles which were stained with 
LysoSensor Blue but were not positive for PkPM4-mCherry, indicating that 
a small proportion of the acidic vesicles may not be functional food 
vacuoles. 
 
 
 
 
 
 
Figure 11. Electron microscopy of P. knowlesi trophozoites. Distinct 
compartments containing small haemozoin crystals (FV) can be seen along 
the inside on the parasite plasma membrane. In the parasite depicted in  
panel A, a region within the parasite can be seen (*) which has the same 
density as the host cell. RBC, red blood cell; PM, parasite membrane; FV, 
food vacuole. Scale bar 1µm. 
A B C 
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4.2. Pkpm4 knockdown using the FKBP DD system. 
4.2.1 pkpm4 knock-out. 
A number of attempts were made to disrupt the pkpm4 locus by double 
crossover integration using three different knock-out constructs with 
different sequences for homologous recombination (Fig. 4, Materials & 
Methods). P. knowlesi was transfected with the linearised constructs using 
the Amaxa transfection system. At least three knock-out attempts for 
each construct were carried out and pyrimethamine resistant parasites 
emerged in each case. Genomic DNA was isolated from emerging 
parasites and this was analysed by PCR for integration of the KO 
construct. None of the constructs were observed to have successfully 
integrated at the pkpm4 locus, suggesting that the gene is essential for 
survival of P.knowlesi blood stage parasites or that technical issues with 
the Amaxa system may hinder efficient integration of the constructs. The 
attempt to knock-out the pkpm4 gene was abandoned and an alternative 
approach was taken to investigate the essentiality of PkPM4 in P. 
knowlesi. 
4.2.2. Knock-down of pkpm4 using the FKBP destablilisation 
domain. 
The FKBP DD system involves the tagging of a gene of interest with a 
destabilisation domain (DD) tag. Once translated, a protein carrying a DD 
tag is rapidly degraded within the cell. Addition of the compound Shield-1, 
which binds to the DD tag, stabilising the protein and protecting it from 
degradation, provides a means in which the levels of a tagged protein of 
interest within the cell can be controlled, allowing the study of protein 
function of essential genes. As the pkpm4 gene was difficult to knock-out, 
this system was applied in an attempt to create a P. knowlesi parasite in 
which the expression levels of PkPM4 could be controlled and to 
determine if the locus was amenable to modification.  
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Figure 12. Replacement of pkpm4 with the vector pkpm4DD. A. Integration strategy of 
pkpm4DD construct. Homologous recombination between the pkpm4 ORF and 3’UTR and 
flanking regions in the construct results in double crossover integration generating a 
modified pkpm4 locus, in which pkpm4 has been replaced with a full-length pkpm4 ORF in 
frame with a 3’ DD tag, under the control of the endogenous pkpm4 promoter. A tg-dhfr/ts 
expression cassette allows for selection with pyrimethamine. B. PCR confirmation of 
construct integration in pm4DD clones 1D2 and 2D5. Primer combinations for checking the 
presence of the wild-type locus (W), P1 and P2, integration at 5’ end (int5), P1 and P3, 
integration at 3’ end (int3), P4 and P2. The intact wild-type locus is absent from both 
clones, while positive results from both reactions int5 and int3 indicate successful 
integration. C. Southern blot analysis of recombinant pkpm4DD locus. P. knowlesi genomic 
DNA was digested with HpaI (restriction sites indicated by ‘H’ in A). A probe specific for a 
portion of the pkpm4 ORF (Probe PM4) detects a 1.5kb HpaI fragment in wild-type P. 
knowlesi, but in pkpm4DD parasites the HpaI fragment is 7.5kb. This can also be detected 
with Probe PM4, but is partially obscured by a shadow on the blot. HpaI-digested 
transfectant DNA displays the same 7.5kb band when probed with Probe TGDHFR, specific 
to a region of the tg-dhfr ORF. 
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The linearised pm4DD integration vector (Fig. 12) was transfected using 
the BioRad electroporator into P. knowlesi schizonts (containing 6-8 
nuclei). The culture was maintained under continuous pyrimethamine 
pressure to select for integrants in the presence of 1µM Shield-1 to 
stabilise the PkPM4DD protein. Pyrimethamine-resistant parasites 
emerged within twenty days. Parasites were cloned by limiting dilution, 
yielding clones 1D2 and 2D5. Genomic DNA was prepared and analysed 
by PCR and Southern blot confirming correct integration of the 
transfection construct and replacement of the endogenous pkpm4 with a 
DD-tagged copy of pkpm4 under the control of the homologous pkpm4 
promoter. (Fig. 12) 
4.2.3. Appearance of WT and pkpm4DD parasites in response to 
Shield-1. 
In complete medium, there is an excess of amino acids, so the parasites 
are not dependent on haemoglobin degradation as the sole source of 
amino acids. When free amino acids are absent in the parasite 
environment, the haemoglobin degradation pathway becomes vital to the 
parasite as an amino acid source. It is expected that parasites lacking a 
functional plasmepsin would be less efficient at haemoglobin degradation 
and thus display a distinct phenotype in amino acid-limited conditions.To 
generate culture conditions with very low levels of free amino acids, 
growth assays were carried out in RPMI-1AA supplemented with 20% 
rhesus macaque serum. Since isoleucine is not found in haemoglobin, it is 
present in RPMI-1AA at the same concentration as in standard RPMI 
medium. Initially, AlbumaxII was intended as a substitute for serum 
(similarly to the growth assays carried out on the P. falciparum quadruple 
plasmepsin knock-out, (16)) but RPMI-1AA supplemented with Albumax II 
would not support the growth of either wild-type or pm4DD P. knowlesi 
parasites in amino acid-limited medium. Instead, rhesus macaque serum 
isolated from blood taken from animals the morning after an overnight 
fast, was used to supplement the medium. Comparing the amino acid 
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concentrations in fasting rhesus serum (127), with free amino acid 
concentrations in RPMI-1640, the concentrations of all amino acids or 
their primary metabolites are 2-10 times lower in rhesus serum (with the 
exception of glycine, histidine, proline, tryptophan and valine which are 
present at comparable concentrations). The culture medium is 
supplemented with 20% rhesus serum, meaning that any free amino 
acids contained in the serum are found at concentrations 5-50 times 
lower in amino acid limited culture medium compared to complete culture 
medium.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. Giemsa stained P. knowlesi wild-type (A-H) and pm4DD (I-P) 
parasites in complete(C) and amino acid-limited(L) medium in the 
presence(+) and absence(-) of 1µM Shield-1. Scale bar 2µM. 
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The appearance of wild-type P. knowlesi appears unaffected by either 
Shield-1 or culture medium (Fig. 13 A-H). The appearance of trophozoites 
and schizonts of pkpm4DD parasites is unaffected by the absence of 
Shield-1 in complete medium (panels K and L), but in amino acid-limited 
medium, pkpm4DD parasites grown in the absence of Shield-1 (panels O 
and P) are much smaller and the cytoplasm of trophozoites and schizonts 
is hardly visible.  
4.2.4. Growth rate of pm4DD parasites in response to Shield-1. 
To investigate the importance of PkPM4 for intraerythrocytic P. knowlesi 
viability, the growth rate of pm4DD parasites was compared to that of 
wild-type P. knowlesi parasites in complete medium and amino acid-
limited medium. Duplicate cultures of both P. knowlesi wild-type and 
pm4DD parasite were prepared in both complete and amino acid-limited 
media and one of each supplemented with 1µM of Shield-1. Cultures were 
propagated alongside each other and the parasitaemia was quantified by 
counting Giemsa-stained smears every 24 hours (± 1 hour) until the 
cultures reached a self-limiting parasitaemia (>3%). The parasitaemia of 
each culture on each day of growth was plotted to compare the effects of 
Shield-1 (Fig. 14). The growth assay was performed twice yielding similar 
results each time. The results of one assay are presented and are 
representative of both growth assays. 
Pm4DD parasites always grow slower than the parental P. knowlesi 
parasites in each culture condition as expected. The growth of wild-type 
P. knowlesi is not affected by the absence of free amino acids in amino 
acid-limited medium (Fig. 14D). However, both pm4DD clones display a 
clear growth deficit in amino acid-limited medium compared to complete 
medium in the absence of Shield-1 (Fig. 14B, C, E, F). This growth deficit 
is partially alleviated for pm4DD parasites grown in amino acid-limited 
medium with 1µM Shield-1, but does not fully revert to the rate of pm4DD 
parasites in complete medium. Increasing the Shield-1 concentration to 
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3µM did not further improve the growth rate (data not shown) indicating 
maximal stabilisation of PkPM4DD occurs with 1µM Shield-1. 
 
 
 
 
 
 
 
 
 
 
 
 
To evaluate the effect of Shield-1 on pm4DD parasites the growth rate 
data were modelled by linear regression. Pm4DD parasites displayed a lag 
phase of three to four days, so the growth rates were analysed after this 
period. Parasite growth should be exponential which would be best 
described using non-linear regression, however due to the slow-growth of 
the pm4DD parasites, a linear model provided the best fit (black lines, 
Fig. 14B, C, E, F). In complete medium, the difference between the slopes 
of the linear models describing growth in the presence and absence of 
Shield-1 were found to be statistically significant for both pm4DD clones: 
1D2, p=0.020; 2D5, p=0.046 (black lines in Fig. 14B, C). The effect of 
Shield-1 is found to be greater on pm4DD parasites in amino acid-limited 
medium as the difference between the slopes of the linear models is even 
A B C 
D E F 
Complete 
Limited 
Figure 14. Growth rate of P. knowlesi wild type and pm4DD parasites in 
response to Shield-1 treatment. Wild-type parasite growth is not affected by 
either Shield-1 treatment or culture medium (A, D). Growth of Pm4DD 
parasites (clones 1D2 and 2D5) is much slower in amino acid limited medium 
(E, F) compared to complete medium (B, C). Black lines in panels B, C, E and F 
represent linear regression models of pm4DD growth rate. 
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more statistically significant: 1D2, p=0.010; 2D5, p<.00001 (black lines 
Fig. 14E, F). Therefore the growth rate of pm4DD parasites in medium 
supplemented with 1µM Shield-1 is significantly higher than the growth 
rate of pm4DD parasites without Shield-1 in both complete and amino 
acid-limited media, strongly suggesting that Shield-1 is protecting 
PkPM4DD from degradation. 
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4.3. PfCRT in P. knowlesi 
4.3.1 Heterologous replacement of pkcrt with pfcrt in P. knowlesi. 
To determine if PfCRT was capable of modulating the chloroquine 
sensitivity of a non-falciparum Plasmodium parasite, closely related to P. 
vivax, which has never been under chloroquine selection, it was 
attempted to replace the P. knowlesi CRT homologue pkcrt, with either a 
CQS or CQR allele of pfcrt. 
Replacement constructs to integrate at the pkcrt locus by double 
crossover integration were kindly provided by Prof. David Fidock 
(Columbia University) (Fig. 3A, Materials and Methods). P. knowlesi 
schizonts were transfected with the linearised replacement vectors using 
the Amaxa transfection system and selected for with pyrimethamine. The 
contructs should integrate by double crossover at the pkcrt locus via the 
homologous flanking regions 5’pkcrt and 3’pkcrt, replacing the 
endogenous pkcrt with either the HB3 or Dd2 pfcrt allele and a h-dhfr 
expression cassette. Pyrimethamine resistant parasites emerged but 
genotypic analysis by PCR indicated that the pkcrt locus remained intact. 
After four successive failures, the replacement of pkcrt with pfcrt was 
abandoned. 
4.3.2 Overexpression of pfcrt  in P. knowlesi from an episome. 
It has previously been demonstrated that overexpression of pfcrt from an 
episome in a CQS P. falciparum parasite could modulate the chloroquine 
sensitivity of that parasite (56). Since pkcrt could not be replaced with 
pfcrt in P. knowlesi, the episomal expression constructs used in P. 
falciparum were obtained from Prof. David Fidock, to investigate if PfCRT 
expressed in trans could modulate the chloroquine sensitivity of P. 
knowlesi. pDC_PfCRT_HB3 and pDC_PfCRT_Dd2trunc constructs 
described in Figure 3B (Materials and Methods), were transfected into P. 
knowlesi using the Amaxa Nucleofector system. Under pyrimethamine 
 74 
selection, transfectants emerged within seven days. Drug assays with 
chloroquine were carried out on the transfectant parasites alongside wild-
type P. knowlesi. Growth inhibition curves representing at least three 
independent drug assays of P. knowlesi pDC_PfCRT_HB3 and 
pDC_PfCRT_Dd2 parasites treated with chloroquine (Fig. 15) and 
corresponding IC50 values (Table 2), display unaltered chloroquine 
sensitivity compared to untransfected P. knowlesi. Plasmid rescues, 
followed by restriction analysis and pfcrt sequencing confirmed the 
presence of the correct vectors with the expected pfcrt sequence in each 
transfectant line. RT-PCR with primers specific for pfcrt confirmed that 
transcripts of both HB3 and Dd2trunc pfcrt were present (data not 
shown). 
 
 
 
 
 
 
 
 
 
4.3.3. Localisation of PfCRT in P. knowlesi. 
The PfCRT Dd2 allele expressed from pDC_PfCRT_Dd2trunc was truncated 
by ten amino acids at the C-terminal. A recent study reports that the 
threonine residue at position 416 in PfCRT is essential for correct 
targeting of PfCRT to the food vacuole in P. falciparum (90). The pfcrt 
protein expressed from pDC_PfCRT_Dd2trunc is missing this residue and 
Figure 15. Growth inhibition curves of P. knowlesi (green), and P. knowlesi 
transfectants pDC_PfCRT_HB3 (blue) and PDC_PfCRT_Dd2trunc (pink) 
presented as mean±standard error. All lines were tested in triplicate in three 
independent assays.  
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is most likely mislocalised in P. knowlesi. This could not be confirmed by 
immunofluorescence assay (IFA) as the only available antibodies for 
PfCRT (rabbit polyclonal, obtained from MR4) react with an epitope in the 
C-terminus of PfCRT (56) which is missing in the truncated protein. 
The same anti-PfCRT polyclonal was used to evaluate the localisation of 
full-length PfCRT in P. knowlesi pDC_PfCRT_HB3 and pDC_PfCRT_Dd2 
transfectants by IFA. However the antibody generated a lot of background 
noise and the location of PfCRT could not be confirmed.  
Since the correct localisation of PfCRT in P. knowlesi could not be verified 
by IFA, the location of a GFP-tagged PfCRT fusion was visualised by 
confocal microscopy. The fusion of pfcrt and gfp was generated by PCR 
and cloned into the expression vector PkCRT-GFP to replace the pkcrt-gfp 
fusion. This expression vector was transfected into P. knowlesi using the 
Amaxa transfection system. Parasites emerged under pyrimethamine 
selection within ten days. P. knowlesi parasites expressing PfCRT-GFP 
exhibit GFP fluorescence with a similar localisation pattern to parasites 
expressing PkCRT-GFP (Fig. 16), in vacuoles also containing haemozoin 
pigment confirming that full-length PfCRT localises correctly to P. knowlesi 
food vacuoles. 
 
 
 
 
 
 
 
 
PfCRT-GFP DIC Merge 
Figure 16. Confocal imaging of full length PfCRT-GFP in P. knowlesi. The 
fluorescently tagged protein can be seen colocalising with haemozoin, 
confirming its correct targeting to food vacuoles. Scale bar 1µm. 
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4.3.4. Episomal expression of full-length PfCRT Dd2 in P. knowlesi. 
To express the full-length PfCRT Dd2 allele in P. knowlesi, the truncated 
open reading frame of PfCRT in pDC_PfCRT_Dd2trunc was replaced with 
the full-length Dd2 open reading frame to generate the 
pDC_PfCRT_Dd2full expression episome, which was transfected into P. 
knowlesi using the Amaxa transfection system. Parasites emerged under 
pyrimethamine selection within ten days and a drug assay was carried out 
(Fig. 17). This preliminary data shows that parasites expressing the full 
length Dd2 allele demonstrate a 4.3-fold increase in IC50 (Table 2) to 
chloroquine compared with wild-type P. knowlesi parasites or P. knowlesi 
parasites overexpressing the CQS allele.  
 
Figure 17. Comparison of growth inhibition curves of P. knowlesi transfectants 
expressing PfCRT alleles from pDC episome. Curves for pDC_HB3 (blue) and 
pDC_Dd2trunc (pink) represent the mean and standard error from three 
independent assays. Inhibition curve (mean from triplicate wells in a single 
assay) of parasites overexpressing the full-length PfCRT Dd2 allele (red) 
indicates increased tolerance to chloroquine. 
 77 
Table 2. Chloroquine IC50 values of Plasmodium parasites 
overexpressing pfcrt alleles in trans. *Fidock et al.(56) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Parasite Episome IC50 (nM) 
P knowlesi - 16.14 ± 1.07 
 pDC_PfCRT_HB3-FLAG 14.80 ± 1.79 
 pDC_PfCRT_Dd2trunc 17.90 ± 0.95 
 pDC_PfCRT_Dd2full 69.1 
   
P. falciparum GC03* - 31 ± 3 
 pDC_PfCRT_HB3-FLAG 32 ± 2 
 pDC_PfCRT_Dd2trunc 53 ± 11 
   
P. falciparum Dd2*  278 ± 27 
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5. Discussion 
5.1. P. knowlesi food vacuole morphology. 
The differences in food vacuole morphology between Plasmodia species 
was first described in a number of early electron microscopy studies in 
which different human, primate, rodent and avian Plasmodium species 
were examined (3, 141). These studies indicated some differences 
between the species but more extensive investigation into the biogenesis 
of the food vacuoles was not possible due to the limited techniques 
available. Interest in the haemoglobin uptake pathway of P. falciparum 
has emerged with the publication of a number of independent studies in 
the past few years. These have focused solely on P. falciparum and while 
using much more modern and informative techniques, appear to have 
largely ignored the existing body of electron microscopy work in different 
Plasmodium species. Some of the uptake mechanisms proposed such as 
vesicle-independent transport of haemoglobin to the food vacuole (94) 
and a large phagotropic event in the ring stage (53) contradict the model 
described by Slomianny (162). However the remaining descriptions of P. 
falciparum haemoglobin uptake are largely consistent with Slomianny’s 
description of micropinocytosis occurring in ring stages, taken over by 
cytostomal uptake as the parasites mature to trophozoites (1, 44, 165). 
P. falciparum and the avian parasite P. lophurae were earlier identified as 
displaying different food vacuole formation compared to the other 
Plasmodium species, where vesicles derived from micropinocytosis and 
the cytostome were combined very early in the asexual cycle to form a 
single central food vacuole to which all the smaller vacuoles are trafficked 
to (141). Considering that there are differences between the species, the 
study of haemoglobin uptake should include non-falciparum Plasmodium 
species such as P. vivax and P. knowlesi. This knowledge will be applied 
to the development of antimalarial therapies which are effective against 
all Plasmodium species which infect man.  
 79 
In this study, a number of specific features of P. knowlesi food vacuole 
biology were investigated using molecular biology and imaging 
techniques. The distribution of haemozoin, the presence of acidic 
compartments and the location of known food vacuole proteins were 
examined to compare the food vacuole dynamics of P. knowlesi to the 
relatively well-characterised P. falciparum food vacuole. 
Differences in haemozoin distribution could be clearly seen in Giemsa-
stained parasites, consistent with early reports that haemoglobin 
degration occurred in multiple locations in P. knowlesi and the related 
species (141). This was supported by LysoSensor Blue staining of live P. 
knowlesi parasites. Multiple acidic vacuoles could be seen in trophozoites 
and early schizonts of P. knowlesi and the compartments stained with 
LysoSensor Blue were even more numerous in P. cynomolgi. 
Are all the different acidic compartments in P. knowlesi and P. cynomolgi 
functioning food vacuoles? A small number of acidic compartments were 
observed which did not contain visible haemozoin crystals. These are 
possibly food vacuoles which have been recently formed and haemoglobin 
degradation has not yet proceeded to the point of haemozoin formation. 
Compartments containing haemozoin pigment which were not acidic were 
also observed in a small number of schizonts. These could be food 
vacuoles in which the pH gradient has been lost due to laser illumination 
(192). 
 
The food vacuole marker proteins PkCRT and PkPM4 were tagged with the 
fluorescent proteins GFP and mCherry respectively, to establish the 
nature of the numerous acidic vesicles and to allow imaging of live P. 
knowlesi food vacuoles without the issues of light-induced loss of pH 
gradient when viewing LysoSensor Blue-stained parasites. 
PkCRT-GFP could be seen in most parasites throughout the cycle, but the 
strongest signal was seen predominantly in schizonts where the 
fluorescently tagged protein displayed colocalisation with pigment-
containing vacuoles and LysoSensor Blue. Since the signal was strongest 
 80 
at a later stage in the cycle when the majority of food vacuoles had 
already fused, PkCRT-GFP localisation in P. knowlesi parasites did not 
provide any useful information regarding food vacuole biogenesis or the 
origin of different acidic vacuoles. 
PkPM4-mCherry was a much more useful marker for food vacuole 
dynamics as it displayed a stronger signal than PkCRT-GFP in trophozoites 
and early schizonts when haemoglobin uptake is at its maximum. PkPM4-
mCherry could be seen in many vacuoles, both with and without pigment. 
Any PkPM4-mCherry vesicles which did not appear to contain pigment 
were most likely food vacuoles in which haemoglobin degradation had not 
proceeded to produce enough visible haemozoin. A faint, diffuse 
fluorescent signal from PkPM4-mCherry could also be seen in the 
daughter merozoites of segmented schizonts. Although not apically 
located, PkPM4 may also play a role in parasite invasion of the red blood 
cell. PM4 has been observed in the micronemes of the ookinete of the 
avian parasite P. gallinaceum where it is involved in invasion of the 
mosquito midgut (98). A role for PgPM4 in merozoite invasion of the red 
cell has not yet been described, but could explain the presence of PkPM4 
on the surface of the merozoites. Alternatively, the protein may be 
localised to the merozoite surface in preparation for haemoglobin 
degradation in the next cycle. 
 
It was considered that the compartments visible by LysoSensor Blue 
staining and fluorescent protein visualisation might be interconnected as 
part of a single tubular network derived from the cytostome, similarly to 
the uptake mechanism proposed by Slomianny and Elliott (53, 162). This 
could be established by FRAP (fluorescence recovery after 
photobleaching) microscopy to selectively bleach one vesicle expressing 
fluorescent food vacuole protein with a laser, then monitor if the 
fluorescent signal returns to the same spot, indicating that the vesicles 
are interconnected and that the fluorescent protein can redistribute to the 
bleached area. Unfortunately this could not be carried out on live P. 
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knowlesi parasites, as the vesicles were too small and moved within the 
cell too quickly. The same reasons prevented pH comparisons between 
different vesicles using the P. knowlesi parasites expressing PfPM4-
pHluorin, which would also have been informative regarding the 
interconnectivity of the different vesicles. 
Electron microscopy of P. knowlesi trophozoites revealed that the 
vacuoles form independently of each other at different points along the 
parasite plasma membrane and are not connected in a network. It could 
not be determined from these images if the vacuoles are derived from the 
cytostome or by micropinocytosis. Serial sectioning of embedded cells 
would provide more information on the uptake processes occurring in 
individual cells. 
 
Transfectant parasites expressing the fluorescently-tagged food vacuole 
proteins were stained with LysoSensor Blue in order to further evaluate 
the nature of the different compartments which may be involved in 
haemoglobin uptake/degradation in P. knowlesi. These experiments 
demonstrated good association between both food vacuole markers and 
LysoSensor Blue staining. However there appeared to be a number of 
acidic vacuoles in P. knowlesi which were stained with LysoSensor Blue, 
but did not contain any food vacuole protein, particularly distinct in 
PkPM4-mCherry parasites. It is possible in confocal images that the signal 
for the LysoSensor Blue or the fluorescent protein are just out of the focal 
plane and are therefore not detected. In the case of each 2D image, a 
number of focal planes through the cell were checked to ensure that the 
presence of fluorescent signal was not missed. To confirm this, confocal 
microscopy was used to generate 3D stacks to compare the localisation of 
acidic vacuoles and PkPM4-mCherry vacuoles throughout whole parasites. 
These experiments clearly indicated the presence of acidic vacuoles in 
trophozoites and early schizonts which did not contain PkPM4-mCherry, 
suggesting that they may not be involved in haemoglobin degradation. 
These could be acidocalcisomes, acidic storage compartments for 
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phosphorus and cations which have been observed in P. falciparum 
merozoites (142). They may only be visible in trophozoites and early 
schizonts and disappear as the parasite matures because they are divided 
and distributed amongst the daughter merozoites and then are simply too 
small to be visible. If these organelles are acidocalcisomes, it is not clear 
why they are not also visible in LysoSensor Blue stained P. falciparum 
trophozoites (192). Since haemoglobin uptake and food vacuole formation 
occurs at a number of different locations on the P. knowlesi plasma 
membrane, the acidic vesicles, which do not contain haemozoin or food 
vacuole protein, may be haemoglobin-containing vacuoles, which simply 
do not have the full complement of food vacuole proteins. Food vacuole 
proteins such as PkPM4 may not be distributed evenly over the parasite 
surface and if haemoglobin uptake is occurring predominantly by 
micropinocytosis at multiple points all along the parasite plasma 
membrane, some food vacuoles may be formed lacking certain 
components. In P. falciparum, the bulk of haemoglobin uptake occurs 
through the cytostome(s) meaning there are fixed points where food 
vacuole proteins must localise before formation of a transport vesicle and 
transformation into a food vacuole. Due to the redundancy in the 
haemoglobin degradation pathway, these vacuoles may still have the 
capability to degrade haemoglobin although less efficiently. Alternatively, 
since the vacuoles ultimately fuse together, the vacuole may simply act 
as a storage vesicle for haemoglobin until it can fuse with another vacuole 
which contains the required protein.  
 
The observations described in this study on P. knowlesi food vacuole 
morphology suggest that the bulk of haemoglobin degradation is carried 
out in small food vacuoles and that the processes which fuse food 
vacuoles in the parasite, are not active as early on in the cycle compared 
to P. falciparum. The differences in food vacuole fusion in P. falciparum 
must be further studied and compared to P. knowlesi to understand the 
molecular mechanisms of vesicle transport and fusion, with particular 
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focus on the role of actin dynamics in both. Micropinocytosis and 
cytostomal uptake may have differential dependencies on actin dynamics 
(53) and actin is probably involved in the subsequent trafficking and 
fusion of food vacuoles (53, 94, 165). The role of actin in P. knowlesi 
haemoglobin uptake and food vacuole fusion should be investigated. If 
the parasite displays a preference for micropinocytosis and does not 
require food vacuole fusion to degrade haemoglobin, does this mean that 
it will be less susceptible to actin inhibitors? It would also be interesting to 
evaluate the factors involved in vesicle trafficking and fusion. In P. 
falciparum there appears to be a strict trafficking pathway for vacuoles 
directly to the main food vacuole. Do food vacuoles in P. knowlesi follow a 
pre-defined transport pathway or do they move randomly within the cell 
until coming into contact with each other and fusing, eventually forming a 
single vacuole in schizont? These vacuoles containing haemozoin can be 
seen moving very fast within the parasite cell when viewed under the 
light microscope but this movement does not appear to be purposeful. 
This stochastic movement could be due to Brownian movement or may be 
an artifact of illumination. 
 
The host cell may have an important influence on the uptake of 
haemoglobin. A single strain of P. berghei (N strain) displays two different 
patterns of haemoglobin uptake depending on whether the parasite has 
invaded a reticulocyte or a mature erythrocyte (163, 164). P. berghei 
parasites in mature red blood cells display an extensive tubular network 
derived from the cytostome, from which food vacuoles bud. Parasites of 
the same strain in reticulocytes however did not form a tubular network 
however and appeared to ingest haemoglobin primarily by 
micropinocytosis (163, 164). This could explain why the vesicles 
containing pigment in P. vivax and P. cynomolgi are much smaller than in 
P. falciparum or P. knowlesi as the bulk of haemoglobin uptake is 
mediated through pinocytosis at a number of locations over the cell 
surface, with the ingestion of much smaller portions of haemoglobin. It 
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would be interesting to study the food vacuole morphology of P. 
falciparum and P. knowlesi in both reticulocytes and mature red blood 
cells to determine if these parasites, which can invade both types of cells, 
display alternate uptake mechanisms depending on the host cell.  
The experiments here indicate that the formation of food vacuoles differs 
considerably between species of Plasmodium that infect man. This should 
be considered in subsequent studies on food vacuole biogenesis and 
efforts should be made to understand the differences in this process 
between species. 
To explore P. knowlesi food vacuole morphology in more depth, the 
respective roles of the two food vacuole marker proteins, PkPM4 and 
PfCRT were further investigated. 
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5.2 Knock-down of PkPM4 in P. knowlesi. 
The plasmepsins are Plasmodium aspartic proteases, four of which are 
located in the P. falciparum food vacuole and are involved in the 
degradation of haemoglobin. All four have been knocked out in P. 
falciparum and the parasites remain viable, although they display a slight 
growth deficiency, particularly when the parasites are grown in medium 
with no free amino acids (16). While the plasmepsins are not essential in 
P. falciparum, there remains considerable interest in them as potential 
drug targets since inhibition of the plasmepsins impedes growth of P. 
falciparum (59, 104, 137). 
The knock-out of pbpm4 in the rodent malaria P. berghei yielded viable 
parasites, which grew to a very high parasitaemia in mice. However, the 
knock-out parasites did not follow the normal course of infection. The 
mice did not develop cerebral malaria, could clear the parasites entirely 
and were protected from subsequent challenge for at least one year 
(166).  
 
These studies establish the food vacuole plasmepsins as interesting 
candidates for study for the development of antimalarials in addition to 
the potential for the development of live-attenuated vaccines. But the 
systems which were used are limited to either in vivo or in vitro study and 
the in vivo data has been generated in a rodent model which may differ in 
the course of malaria infection and the host response in humans. P. 
knowlesi is closely related to a relevant human pathogen, P. vivax (123) 
and is becoming recognised as a serious human zoonosis in its own right 
(36). It can be used for in vitro manipulations as well as in vivo studies in 
an experimental host which is phylogenetically closely related to humans, 
yielding biologically relevant data. This identifies P. knowlesi as a versatile 
and informative system with which to study the potential of parasite 
proteins as drug targets or live-attenuated parasites as vaccines. Thus, 
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the essentiality of the single food vacuole plasmepsin, PkPM4 in P. 
knowlesi was investigated initially in in vitro studies. 
 
The disruption of the pkpm4 by double crossover integration could not be 
achieved with three different knock-out constructs, suggesting that the 
gene was essential. However, recent experiments in our lab suggest that 
double crossover integration may not be very efficient using the Amaxa 
nucleofector system as compared to the BioRad system. Therefore, no 
absolute conclusions can be made on the essentiality of pkpm4 based 
solely on the knock-out attempts. To further probe the essentiality of 
pkpm4 and to study the phenotype of parasites in which the PkPM4 
protein is absent, the regulatable FKBP destabilisation domain (DD) 
system was applied for the first time in P. knowlesi. The DD tag allows for 
control of the levels of protein in response to the concentration of the 
compound Shield-1. In the absence of Shield-1, the protein is degraded, 
on addition of Shield-1 to the culture medium, the Shield-1 binds to the 
DD tag and prevents degradation of the protein. The pkpm4 locus was 
modified by double crossover integration (using the BioRad system) to 
generate the full pkpm4 ORF with an in-frame 3’ dd tag under the 
endogenous pkpm4 promoter, generating parasites pm4DD. 
 
To confirm control of PkPM4DD in response to Shield-1 concentration, 
Western blots were carried out with two different antibodies directed 
against the DD tag, but detection of the PkPM4DD protein was 
unsuccessful. A polyclonal antibody specific for PkPM4 is currently in 
production and will soon be available for the comparison of PkPM4DD 
levels in +Shield-1 and –Shield-1 cultured parasites. 
 
Although control of PkPM4DD levels in response to Shield-1 has not yet 
been confirmed, pm4DD parasites display a distinct phenotype in the 
absence of Shield-1, highly suggestive of regulated protein levels. In 
amino acid-limited medium, the morphology of Giemsa-stained pm4DD 
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parasites is different compared to wild-type parasites in the absence of 
Shield-1. The pm4DD parasites do not grow within the red blood cell to 
the same size as the wild-type parasites (Fig. 13O, P). This is probably a 
consequence of inhibition of protein synthesis, due to the decreased 
availability of amino acids in amino acid-limited medium and insufficient 
levels of a functional PkPM4. The appearance of pm4DD parasites in 
amino acid-limited medium (particularly in the absence of Shield-1) was 
problematic for accurate evaluation of the growth rates of the cultures. A 
large proportion of pm4DD parasites appeared to be dead in the Giemsa 
smears, introducing a level of variation in the parasite counts. This may 
be improved by using FACS analysis of fluorescently stained parasites 
differentiating dead and living parasites. This could then be incorporated 
into the calculations of parasitaemia. In spite of this complicating factor, 
the parasite levels in pkpm4DD cultures were suitably quantified to allow 
comparison of pm4DD growth rates. Pm4DD parasites display a 
significant difference in growth rate in response to Shield-1 in both 
complete and amino acid-limited media (Fig. 14B, C, E, F), suggesting 
Shield-1-dependent control of PkPM4DD levels. The growth of wild type P. 
knowlesi parasites remains unchanged in the absence of free amino acids 
in the medium, indicating that the haemoglobin degradation pathway 
provides sufficient amino acids for protein synthesis. The wild type 
parasite is also unaffected by the presence of 1µM Shield-1. However the 
growth of pm4DD parasites in complete medium is lower compared to the 
wild-type, despite the presence of Shield-1 which should stabilise the 
PkPM4DD protein. There may be several reasons for this. The Shield-1 
compound may not stabilise sufficient levels of the enzyme to efficiently 
process enough haemoglobin to provide sufficient amino acids for protein 
synthesis. Increasing the Shield-1 concentration to 3µM did not cause 
pm4DD growth to revert to wild type levels (data not shown), indicating 
that Shield-1 concentration may not be the limiting factor. Alternatively, 
the presence of the DD tag on PkPM4 may interfere with the trafficking of 
the protein to the food vacuole, or inhibit the function of the protein. 
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Another reason for lower growth rates of pm4DD in the presence of 
Shield-1, could be due to modification of the pkpm4 locus i.e. changing 
the endogenous pkpm4 3’UTR to the pycrt 3’UTR which could alter pkpm4 
transcription levels. This could be verified by quantitative PCR, however 
our primary interest is in the control of PkPM4DD protein levels in 
response to Shield-1 and this data will be available soon. 
 
The presence of Shield-1 had a significant effect on pm4DD parasites in 
both complete and amino acid-limiting medium, however the effect of 
Shield-1 was more significant on pm4DD parasite growth in amino acid-
limited medium (Fig. 14E, F). This is an indication of the importance of 
PkPM4 for efficient haemoglobin degradation, particularly when external 
amino acid levels are low. However, P. knowlesi pm4DD parasites grown 
in the absence of Shield-1, demonstrate slightly higher growth rates than 
the P. falciparum quadruple knock-out parasites in amino acid-limiting 
medium (16). This could be due to a number of reasons, such as 
“leakiness” of the DD-tag (7) in which a small level of PkPM4DD may 
escape degradation and is active in the food vacuole. In addition, the use 
of rhesus serum to supplement the medium, instead of AlbumaxII, might 
mean there are more free amino acids available to the parasites, although 
these levels are clearly much lower than amino acid levels in complete 
culture medium. These data suggest that PkPM4DD levels are regulated 
by Shield-1, but this is awaiting confirmation by Western blotting. 
 
Is PkPM4 essential for in vitro growth of P. knowlesi? Knock-out 
experiments suggest that it is, since the pkpm4 ORF was refractory to 
disruption, however this may be due to a technical issue rather than the 
essentiality of pkpm4. This inducible knock-down experiments using the 
DD-tagged PkPM4 indicate that P. knowlesi is viable without (or with low 
levels of) a functional PkPM4 in the food vacuole, but growth rates are 
diminished. Quantification of PkPM4DD levels in +Shield-1 and –Shield-1 
parasites is crucial before any conclusions about the essentiality of PkPM4 
 89 
may be made, however the appearance and growth rate of PkPM4DD 
parasites in amino acid-limiting medium in the absence of Shield-1 
strongly suggest that the insufficient levels of a functional PkPM4 enzyme 
has an adverse effect on parasite viability and this may explain why the 
knock-out parasites are very difficult to obtain. In addition, these 
experiments underline the value of appropriate regulatable systems in 
Plasmodium. 
 
The cysteine protease orthologues of the P. falciparum falcipains are also 
present in the food vacuole and probably compensate for the absence of 
the plasmepsin. In this case, haemoglobin degradation is less efficient but 
can still proceed at a rate which provides sufficient amino acids to support 
parasite growth. It may also be possible that there are additional 
proteases present in the P. knowlesi food vacuole. P. falciparum has 
created redundancy in this catabolic pathway through duplication of the 
plasmepsins, perhaps the other Plasmodium species that all have a single 
plasmepsin in their genomes, have evolved an alternative mechanism of 
redundancy in the form of other proteases which have yet to be identified 
in the food vacuole.  
 
Although the knock-down of PkPM4 is clearly detrimental to P. knowlesi 
erythrocytic growth when there are no available amino acids in the 
medium, this may not be an accurate representation of in vivo conditions 
in the host. It would be interesting to evaluate the viability and virulence 
of the P. knowlesi pm4DD knock-down parasites in the experimental 
primate host, to compare the course of infection with the P. berghei 
plasmepsin knock-out in mice. Given the remarkable observation of long-
lasting protective immunity induced by the plasmepsin knock-out P. 
berghei in mice, it would be interesting to investigate if the P. knowlesi 
plasmepsin knock-down parasites can induce a similar protective 
response in primates, then opening avenues to the development of live-
attenuated vaccines. 
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The levels of redundancy in this Plasmodium biochemical pathway reflects 
the importance of this pathway to the parasite, but will certainly blight 
any drug strategies which may be developed against any single 
component of the pathway such as the plasmepsins. For successful 
inhibition of parasite growth by disruption of the haemoglobin degradation 
pathway, multiple enzymes will have to be targeted. However, the 
potential of genetically modified parasites as live-attentuated vaccines 
remains intriguing and the P. knowlesi pm4DD parasites could be a useful 
tool to gain valuable insight into this promising route to an effective 
malaria vaccine. 
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5.3. Heterologous expression of PfCRT in P. knowlesi. 
 
Chloroquine resistance in P. falciparum has been well characterised with 
PfCRT convincingly implicated as the main facilitator of chloroquine 
transport out of the food vacuole. The second most prevalent human 
malaria species, P. vivax has also developed resistance to chloroquine (40 
years behind P. falciparum) but there has been no factor definitively 
linked to chloroquine treatment failure. PvCRT alleles in P. vivax 
chloroquine resistant strains have not been found to carry any mutations 
compared to CQS strains. This indicates that a different mechanism of 
resistance is present in P. vivax. In addition, a recent study on P. vivax 
clinical isolates reports that P. vivax rings are more susceptible to 
chloroquine than trophozoites (154), unlike P. falciparum, where 
trophozoites are the most susceptibile stage to chloroquine. This is 
suggestive of a different mechanism of action of the drug between the 
species. Given the difficulties associated with in vitro cultivation of P. 
vivax, the closely related P. knowlesi parasite was used to investigate the 
ability of PfCRT to modulate CQR. If the expression of a chloroquine 
resistant allele of PfCRT in the P. knowlesi food vacuole modulates the 
chloroquine sensitivity of P. knowlesi, it would implicate the food vacuole 
as a site of action for chloroquine in “vivax-type” parasites. 
 
The endogenous pkcrt could not be replaced with either CQS or CQR 
alleles of pfcrt. This may be due to the essential nature of the gene, 
where any modification of the pkcrt locus would affect parasite viability  It 
may also be due to the unavailability of the locus for double crossover 
integration. This can be tested by attempting heterologous integration at 
the pkcrt locus, in which an integration construct replaces the genomic 
pkcrt with a cDNA copy of itself. This was attempted once with the Amaxa 
transfection system without success. In the course of this work however, 
doubts were raised as to the efficiency of the Amaxa system compared to 
the Biorad system for double crossover integration in P. knowlesi, thus 
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the difficulties encountered in replacing pkcrt with pfcrt may also simply 
be explained by technical issues. 
  
As an alternative to replacement of pkcrt, episomal overexpression of 
pfcrt should give an indication if chloroquine resistant alleles of pfcrt 
would be capable of modulating chloroquine resistance in P. knowlesi. 
Overexpression of the HB3 (chloroquine sensitive) allele of pfcrt did not 
modulate the sensitivity of the parasites to chloroquine compared to wild-
type P. knowlesi. This was to be expected since there are no mutations 
present in the protein which would allow it to facilitate chloroquine 
diffusion/transport out of the food vacuole, and overexpression would not 
change this. 
The overexpression of Dd2 allele of PfCRTtrunc (missing ten amino acids 
from the C-terminus) gave rise to a 1.5-fold increase in CQ IC50 in P. 
falciparum (56) but did not significantly affect the sensitivity of P. 
knowlesi to chloroquine. This can be explained in light of the recent study 
published by Kuhn et al. in which they demonstrated that the threonine 
residue at position 416 (missing in PfCRT Dd2trunc) was required for 
correct targeting of PfCRT to the P. falciparum food vacuole (90). A 
truncated PfCRT molecule which was missing this residue was localised to 
the P. falciparum plasma membrane. So it is possible that PfCRT Dd2trunc 
did not modulate the tolerance of P. knowlesi to chloroquine as it may 
have been mistargeted to the parasite plasma membrane. It is intruiging 
that the truncated PfCRT Dd2 molecule increased the chloroquine IC50 of 
the chloroquine sensitive GC03 strain P. falciparum 1.5-fold, considering 
that the protein did not have the necessary sequence information for 
correct localisation to the food vacuole. Since the truncated PfCRT is 
trafficked as far as the plasma membrane, it is possible that a small 
proportion of truncated PfCRT was located close to the cytostome or at 
other points of haemoglobin uptake on the membrane and by chance was 
transported to the food vacuole in the haemoglobin transport vesicles 
along with other food vacuole proteins which are trafficked in this 
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manner. A similar, 1.5-fold increase in IC50 was not displayed when the 
truncated PfCRT was overexpressed in P. knowlesi. P. knowlesi has never 
been under any form of selection pressure from chloroquine, while even 
the CQS in vitro strains of P. falciparum have been adapted after the 
introduction of chloroquine to the clinic, so it can be assumed that they 
have accumulated some level of background mutations which can 
modulate chloroquine tolerance. It has recently been reported that the 
genetic background of P. falciparum parasites is important in “fine-tuning” 
the level of chloroquine tolerance in the presence of mutated pfcrt. 
Different chloroquine sensitive strains of P. falciparum were transfected to 
replace the endogenous pfcrt with a chloroquine resistant pfcrt allele 
(from P. falciparum 7G8). The different strains all displayed different 
levels of chloroquine tolerance despite expressing the same pfcrt allele 
(179). It is relevant to note that the GC03 strain in which the episomal 
expression of truncated PfCRT increased the IC50 1.5-fold (56), displayed 
the largest increase in chloroquine IC50 of all the chloroquine sensitive 
lines in which the pfcrt allele had been replaced (179). This indicates that 
GC03 has probably accumulated most of the additional polymorphisms in 
other loci which contribute to the chloroquine resistance phenotype and 
therefore can be expected to display the most significant change in 
chloroquine tolerance, even with a small quantity of PfCRT Dd2trunc 
located in the food vacuole. 
 
The full-length Dd2 PfCRT allele could not be overexpressed in P. 
falciparum from a plasmid (56), however the full-length Dd2 PfCRT allele 
was successfully overexpressed in P. knowlesi, although the parasites 
displayed a slight growth deficit. Preliminary data (from a single assay in 
triplicate wells) on these transfectant parasites, indicates that the full-
length PfCRT is capable of modulating chloroquine tolerance of P. 
knowlesi. This is the first evidence of the modulation of chloroquine 
resistance by PfCRT in a non-falciparum Plasmodium parasite. 
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The four-fold increase in IC50 conferred by overexpression of PfCRT 
Dd2full in P. knowlesi does not exceed the threshold for chloroquine 
resistance in the clinic (80-100nM) (52). It is comparable however, to the 
increase in chloroquine IC50 of the chloroquine sensitive P. falciparum 
strain 3D7, when the endogenous pfcrt was replaced with the chloroquine 
resistant 7G8 pfcrt allele (179), emphasising the importance of mutations 
in other loci to the chloroquine resistance phenotype. It must also be kept 
in mind that episomal expression of a gene, even under a strong 
constitutive promoter, can result in varied expression levels between 
parasites, due to differences in episome copy number. Therefore a drug 
assay on episomal transfectants is assaying a heterogenous population of 
parasites with differing levels of gene expression. For a more conclusive 
evaluation of the role of PfCRT in modulating chloroquine tolerance in P. 
knowlesi, pfcrt should be expressed in P. knowlesi without expression of 
the endogenous pkcrt. This study demonstrates that direct replacement of 
pkcrt with pfcrt is challenging. However, an integration construct could be 
engineered to replace pkcrt with a copy tagged with the FKBP 
destabilisation domain, allowing control of PkCRT levels. The same 
integration construct could carry a pfcrt expression cassette, which would 
generate in a parasite line which bears both PkCRT and PfCRT in the 
presence of Shield, but only PfCRT when Shield is absent, thus allowing 
evaluation of the chloroquine sensitivity of the parasite due entirely to the 
PfCRT molecule. 
 
This study has demonstrated that chloroquine must exert a toxic effect in 
the food vacuole of P. knowlesi, a “vivax-type” parasite, as a molecule 
located in the food vacuole modulates the activity of chloroquine in the 
parasite. However, there may be an additional site of action for 
chloroquine in Plasmodium parasites. In consideration of the reported 
difference in chloroquine stage sensitivity between P. falciparum and P. 
vivax (154), it is possible that the toxic effect exerted by chloroquine is 
more potent in different locations in different species. A small number of 
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studies on P. falciparum suggest that the nucleus may be an additional 
site of chloroquine action. Chloroquine is known to intercalate with double 
stranded DNA (32, 124) and chloroquine treatment has been shown to 
cause DNA fragmentation in a chloroquine sensitive strain P. falciparum 
but not a chloroquine resistant strain (128). It has been reported that a P. 
falciparum chloroquine resistance marker protein with polymorphisms 
which correlate with choroquine resistance, localises to the nucleus in 
chloroquine sensitive parasites but can be found in the cytoplasm around 
the nucleus in chloroquine resistant parasites (99, 100). Chloroquine 
sensitive P. falciparum schizonts have also been reported to produce less 
nuclei after chloroquine treatment, possibly due to interference of 
chloroquine with DNA synthesis and the merozoites which are formed 
after chloroquine treatment display a “delayed death” in the next cycle 
(63). If the nucleus of P. vivax is more susceptibile to chloroquine toxicity 
than P. falciparum, it may explain the differential stage sensitivities and 
possibly the difference in resistance mechanisms between the two 
parasite species. 
 
Chloroquine resistance in Plasmodium appears to be a multifactorial 
response of the parasite to which, PfCRT is most strongly associated to, 
but by no means the sole contributor. It would be interesting to further 
investigate other proteins which contain polymorphisms correlating to 
chloroquine resistance in order to identify players in P. vivax drug 
resistance and improve our understanding of the mode of action of 
chloroquine in all Plasmodium species. 
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6. Conclusions. 
 
A number of facets of food vacuole biology of P. knowlesi have been 
described and compared to existing data on P. falciparum food vacuole 
biology. The morphology of this lysosome-like organelle is strikingly 
different between P. falciparum and P. knowlesi and the other “vivax-
type” parasites examined. It is unclear if this stems from differences in 
uptake mechanism or vesicle fusion dynamics. These differences should 
be borne in mind if inhibitors of these essential processes are to be 
developed as antimalarial compounds. 
 
The implementation of an inducible protein expression system in P. 
knowlesi for the first time allowed the characterisation of the phenotype 
of P. knowlesi lacking a functional plasmepsin protein. Knock-down of 
PkPM4 in P. knowlesi resulted in a growth deficit in both amino acid-rich 
and amino-acid limited media indicating a disruption in nutrient 
acquisition. If complete knock-down of PkPM4 can be confirmed, this 
parasite line may be used for in vivo studies to assess the potential of 
live-attenuated Plasmodium parasites as a malaria vaccine. 
 
Episomal expression of a PfCRT allele from a chloroquine resistant P. 
falciparum parasite in P. knowlesi demonstrated that PfCRT is sufficient to 
modulate the chloroquine sensitivity of P. knowlesi. This indicates that 
chloroquine does exert a toxic effect in the food vacuole of “vivax-type” 
parasites despite apparent differences in stage sensitivity and a different 
mechanism of choroquine resistance in P. vivax compared to P. 
falciparum. 
 
Existing data on Plasmodium food vacuoles is limited to observations in P. 
falciparum, which fails to identify any species-specific differences. P. 
falciparum can only be studied in vitro, apart from highly artificial in vivo 
infections in splenectomised Aotus monkeys or humanised mice. This 
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limits in vivo studies to artificial conditions which do not necessarily 
represent natural infection or rodent models which may not mirror human 
disease. The studies described in this thesis highlight the value of P. 
knowlesi in vitro culture and transfection technology for understanding 
the biology of Plasmodium parasites which infect humans, considering the 
intractability of P. vivax. P. knowlesi culture and transfection can be 
effectively used in parallel with P. falciparum, to complement experiments 
in P. falciparum and give a more broad and informative view to the 
biology of more Plasmodium species which infect man. 
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